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 Patients undergoing general anesthesia who have or are suspected of obstructive sleep 
apnea (OSA) may be at increased risk for ventilatory complications, including respiratory 
depression, airway obstructions, and apnea events.  The increased prevalence of OSA in the 
surgical population has led clinicians and researchers to explore strategies to screen for OSA and 
employ best management practices to minimize perioperative respiratory events.  Standardized 
monitors in the postoperative anesthesia care unit (PACU) may have limited utility in this patient 
population to readily detect real or potential airway complications.  The purposes of this 
prospective observational study were: to further explore the relationship of OSA risk to 
perioperative events in participants undergoing laparoscopic gastric bypass surgery (GBS); 
explore the utility of using an innovate respiratory volume monitor (RVM, ExSpironTM, 
Waltham, MA, USA) to identify reduced ventilatory function before standard postoperative 
monitors alert nurses of hypoventilation or apnea events; measure the ventilatory changes when 
noninvasive positive pressure therapy (NPPV) was applied in the PACU using the RVM.  A 
prospective convenience sample of 50 adult participants with 25 assigned as “mild OSA” (M-
OSA) and 25 in the “moderate/severe OSA” (S-OSA) were selected and observed in the PACU 
	
	
to explore the research questions.  Findings included no differences perioperative outcomes with 
the exception of longer PACU stay mean times for the M-OSA, despite S-OSA group being 
older, having larger neck circumferences, and receiving more opioids in the PACU.  The RVM 
identified respiratory depression events earlier and more often than decreases in pulse oximetry.  
Thirteen participants who received NPPV and had no significant change in minute ventilation 
(MV) during use, however a mean decrease of 25% in tidal volume (TV) was measured from 
mask removal time to five-minute post removal period.  This supports the effects of NPPV on 
maintaining MV when measured by RVM.  Findings of the study help support the need to further 
explore the utility of using RVM to measure ventilatory function, guide therapies, and 
incorporate RVM into practice settings where patient populations are at risk for respiratory 
complications.  The use of postoperative NPPV therapy needs further exploration in randomized 
studies to identify optimal NPPV type, pressure settings, and duration of use to help improve 
ventilatory function in patients known to or suspected of having OSA.  
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CHAPTER 1: STATEMENT OF THE PROBLEM 
Introduction 
 Approximately 2-4% of the U.S. population is diagnosed with obstructive sleep apnea 
(OSA).  Twenty to thirty percent of surgical candidates, and upward of 90% of bariatric surgical 
patients (Finkel et al., 2009) have OSA but are undiagnosed prior to surgery.  This population is 
at risk for inadequate ventilation and hypoxia (Liao, Yegneswaran, Vairavanathan, Zilberman, & 
Chung, 2009; Mador et al., 2013), requiring interventions to improve respiratory function (Kaw, 
Pasupuleti, Walker, Ramaswamy, & Folvary-Schafer, 2012).  Diagnosing the etiology of altered 
ventilatory patterns in patients with known or suspected OSA can be difficult, and lead 
anesthesia providers to initiate interventions when respiratory depression occurs that may not 
result in expected outcomes.  Perioperative airway management requires accurate identification 
of ventilatory problems and subsequent implementation of appropriate interventions.  In patients 
with OSA, this may be even more essential.   
 Postoperative hypoventilation and apneic events can delay recovery, increase risks for 
perioperative morbidity and mortality, and add tens of thousands of dollars of additional expense 
to patients and healthcare systems (Kapur, 2010; Shin, Zaremba, Devine, Nikolov, Kurth, & 
Eikermann, 2016).  Researchers conducted meta-analyses and found that patients with OSA have 
increased odds of respiratory failures, cardiovascular events, oxygen desaturations, ICU 
admissions, and increased lengths of hospital stay (Kaw et al., 2012; Hai et al., 2014).  These 
events may be avoided with appropriate screening, perioperative monitoring, and timely 




 Gupta, Parvizi, Hanssen, and Gay (2001) explored perioperative complications associated 
with patients who have of OSA.  In their retrospective case-controlled analysis of 202 patients 
undergoing orthopedic surgery they reported that patients with OSA had a two-fold risk of 
experiencing adverse perioperative events.  Serious complications occurred in 24% of patients 
with OSA vs. 9% of the control group.  Continuous positive airway pressure (CPAP) therapy 
applied prophylactically eliminated airway complications during the first postoperative night.  
 Opperer et al. (2016) conducted a systematic review of 61 studies concerning OSA 
positive or suspected patients who had ≥ 1 adverse postoperative outcome after anesthesia.  The 
analysis included 413,304 OSA positive patients and 8,556,270 in control groups.  They reported 
that patients with OSA have a higher incidence of adverse cardiopulmonary events (Gupta et al., 
2001; Mokhlesi, Hovda, Vekhter, Arora, Chung, & Meltzer, 2013), re-intubation (Memtsoudis, 
Liu, Ma, Chiu, Walz, Gaber-Baylis, & Mazumdar, 2011), hypoxemia, and increased length of 
hospital stay (Kaw et al., 2012).  Liao et al. (2009) reported in a retrospective cohort study (240 
matched pairs) that overall postoperative complications associated with patients who had OSA 
was 48% compared to 28% in control group.  Patients with OSA required longer oxygen therapy 
(23% OSA vs. 15% non-OSA), additional monitoring (13% OSA vs. 6% non-OSA) and had 
higher rates of ICU admissions (40% OSA vs. 28% non-OSA).  They further reported that 
patients with OSA who were non-compliant with CPAP exhibited the “highest incidence of 
postoperative complications” (p. 823), with oxygen desaturations most commonly noted.  Since 
most of these were retrospective studies, the authors concluded that randomized prospective 
control studies are needed.  They suggested exploring the relationship of OSA severity with 
perioperative outcomes, including the effects of CPAP therapy, and monitoring strategies to 
improve patient outcomes. 
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 In 2005, the American Society of Anesthesiologists (ASA) established a task force in 
order to study the prevalence of OSA and suggest best perioperative management strategies.  
They published preliminary guidelines (Gross et al., 2006) on perioperative screening and 
general management of patients with OSA in the perioperative setting.  Updates (Gross et al. 
2014) addressed collaboration with surgeons, recommendations for sleep study referrals, and 
strategies to optimize perioperative ventilation in patients with OSA.  Recommendations also 
included strategies for patient positioning (upright vs. supine), reducing opioid use, and utilizing 
regional anesthesia techniques when feasible.  Despite the general recommendations, no formal 
practice standards were adopted.  Instead, broad guidelines for patients with OSA undergoing 
surgical procedures were provided, allowing practitioners and health care systems to customize 
individual patient management.  They too advocated for prospective randomized control trials to 
explore perioperative implications of OSA and to standardize practice guidelines for anesthesia 
providers (Stewart, 2013).   
 There are several aims in this dissertation research.  One aim is to explore relationships 
between OSA severity and postoperative ventilation patterns (minute ventilation and 
perioperative vital signs).  A second aim is to document direct effects of postoperative non-
invasive positive pressure ventilation (NPPV) in this group.  A third aim is to provide additional 
insight into standardized screening of patients with OSA, the measures used to detect apnea and 





Background and Significance of Obstructive Sleep Apnea 
The Physiology of Obstructive Sleep Apnea 
 Patients with a diagnosis of OSA have altered airflow patterns during sleep that lead to 
reductions in pharyngeal muscular tone, specifically the genioglossus dilator muscle that is 
associated with a reduction or cessation in airflow to the lungs.  The changes to airflow can be 
demonstrated in Pouseille’s law, where flow is proportional of the radius to the fourth power and 
inversely proportional the length of the lumen (Susarla, Thomas, Abramson, & Kaban, 2010).  
This means that decreasing the radius of a lumen, such as the trachea by half will decrease the 
flow 16-fold.  Upper airway pharyngeal dilating tone decreases in patients with OSA, leading to 
narrowed and/or an obstructed airways.  Because of narrower hypopharyngeal structures, 
patients with OSA are predisposed to obstructive airflow patterns under normal circumstances.  
And the risk for obstruction is compounded in the perioperative setting due to the effects of 
medications, anesthesia, and alterations in sleep structure after surgery.   
 The time spent in OSA breathing patterns include hypopnea or apneic events, defined as 
periods of reduced (<50% airflow) or absent  (>90% reduction) airflow for >10 seconds when 
simultaneous chest/abdominal exertions are noted (Cropsey, & McEvoy, 2017; Moos, Prasch, 
Cantral, Huls, & Cuddeford, 2005).  Unlike central sleep apnea where a cessation of airflow 
accompanies no skeletal/diaphragm exertion, the diaphragm, and chest attempts to move against 
closed glottic structures.  Ultimately, the individual gasps for air, often awakening momentarily, 
increasing the percentage of fragmented sleep.  Figure 1 (Jordan, White, & Fogel, 2003) depicts 
a physiological model of an OSA sleep pattern with plausible pathophysiological factors.  
 
Figure 1: Model of OSA sleep cycle. Model moves in a clockwise direction. UA: Upper Airway 






Note: Figure 1 from “Recent advances in understanding the pathogenesis of OSA,” by A.S. 
Jordan, D.P. White, and R.B. Fogel, 2003, Current Opinion in Pulmonary Medicine, Volume 9, 
p. 460. Copyright [2003] by Lippincott Williams & Wilkins (Wolters Kluwer Health Inc.). 
Reprinted with permission.  
 
 Sleep patterns in those with OSA become fragmented from repeated awakenings caused 
by reduced or obstructed airflow.  Remodeling of the airway and reduced quality of sleep 
increases daytime somnolence, affecting activity levels and cognitive function.  These alterations 
can hinder diet and exercise patterns, increase body weight, and add stress to other physiological 
systems.  Rapid eye movement (REM) sleep percentages increase with escalating periods of 
obstructive airflow and fragmented sleep.   
 Over time, alterations in airflow increase circulating carbon dioxide levels (CO2), 
vascular tone, and sympathetic catecholamine levels, and lead to right-sided heart strain.  
Changes in electrical conduction pathways can occur because of the cardiovascular strain and 
lead to increased risk for uncontrolled hypertension (Marcus, Pothineni, Marcus, & Bisognano, 
2014) and/or atrial fibrillation (Lin et al., 2015; Sidhu & Tang, 2017).  Physiological changes 
then reduce the central nervous system's sensitivity to circulating CO2, making the person less 
arousable, which can decrease their daytime energy levels, ability to concentrate, or stay awake 
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(Jordan, McSharry, & Malhotra, 2014).  These changes in sleep patterns are associated with 
increased risk for airway decompensation and adverse airway events in the perioperative setting 
(Paje & Kremer, 2006).  
Co-Morbidities associated with OSA 
 OSA can be independent of other disease processes, but typically coincides with other 
health issues (e.g., diabetes, hypertension, arrhythmias, stroke, obesity, and higher BMI scores)  
(Dempsey, Veasey, Morgan, & O'Donnell, 2010).  The long-term physiological effects described 
by Grippi et al. (2015) include changes in neurocognitive function, increased cardiovascular 
strain, hypercoagulability, endocrine dysregulation, additional oxidative stress, increased 
inflammation, and endothelial dysfunction.  The compounded effects of co-morbidities lead to an 
increased risk of perioperative morbidity and mortality and worsening OSA (Chung et al., 2016).  
 Individuals who have OSA but are undiagnosed, may have additional perioperative 
complications.  It has been demonstrated that undiagnosed patients are at increased risk for 
cardiovascular complications (Liao et al., 2009).  Mutter, Chateau, Moffatt, Ramsey, Roos, and 
Kryger, (2014) compared postoperative outcomes in undiagnosed and diagnosed OSA patients to 
low-risk/non-OSA groups, measuring longitudinal data for 21 years.  They documented an 
increased risk of pulmonary complications in all OSA groups compared to controls (OR 2.08, 
[CI 1.35 to 2.19]).  The incidence increased as the severity of OSA worsened.  Patients with 
undiagnosed OSA had higher incidence of cardiovascular complications and shock (OR 2.20 [CI 
1.16 to 4.17]) compared to matched controls.  They reported that the use of CPAP therapy 
reduced these risks.  These researchers advocated for prospective/randomized studies to evaluate 
the efficacy of CPAP in both subgroups.  Preoperative polysomnography (PSG) is the gold 
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standard for diagnosing OSA.  PSG is not performed on all surgical patients, increasing the risk 
of missing the identification of OSA on patients scheduled for surgery and anesthesia. 
OSA Screening Tools 
 The gold standard for diagnosing and classifying the severity of OSA is through a PSG 
study performed in a sleep study lab (Jordan et al., 2014).  In these studies, 
electroencephalography, electrocardiography (ECG) electrodes, airflow sensors, and chest 
impedance devices are attached to patients.  A technician monitors and records respiratory 
changes in airflow patterns, chest movement, and depth of sleep.  Altered airflow patterns, 
typically seen during REM sleep, are recorded during the PSG study.  A diagnosis of OSA is 
confirmed when periods of hypoventilation (>30-50% airflow reduction) or apneustic (>90% 
airflow reduction for >10 seconds) breathing patterns are identified, measured, and averaged 
(Abrishami, Khajehdehi, & Chung, 2010; Boese, Ransom, Roadfuss, Todd, & McGuire, 2014; 
Chung, Liao, Yegneswaran, Shapiro, & Kang, 2014).  The average number of these events per 
hour of sleep determines the apneustic/hypopnea index (AHI).  A higher AHI correlates with 
more severe OSA. 
 A diagnosis of mild OSA is defined to include 5 to <15 AHI events/hour, moderate, 15-
30 events/hour, or severe, >30 events/hour (Chung, Yang, Brown & Liao, 2014; Chung et al., 
2016).  Sleep efficiency is determined to be normal if there is >80% of total sleep to REM sleep 
(sleep efficiency = (total sleep time – REM)/total sleep) x 100).  After a positive OSA diagnosis, 
individuals with moderate and severe OSA are often offered treatment.  Typically this involves 
fitting them with a nasal or full-face mask that provides NPPV through continuous or bi-level 
positive airway pressure (CPAP and BiPAP respectively).  The goal is to assist in maintaining a 
patent hypopharnyx and improve airflow during sleep.  A second sleep test is then conducted to 
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properly fit the mask and adjust pressure settings to open the closed airway, attenuate obstructive 
airflow, and reduce AHI severity.  
 The PSG is effective in diagnosing OSA, however it is time-consuming and expensive.  
Therefore, many patients who present for surgery may actually have OSA, without a formal 
diagnosis.  Gross et al. (2014) suggests preoperative screening is essential to identifying potential 
issues in surgical candidates, and identifying those who may benefit from preoperative sleep 
studies.  In patients who are suspected of having OSA without the benefit of a formal diagnosis, 
screening questionnaires may be useful (Abrishami et al., 2010).  These tools if utilized 
preoperatively, may alert anesthesia providers of likelihood of OSA so they can anticipate 
associated complications during surgery  
 The STOP-Bang questionnaire (SBQ) (Appendix C) is an eight-item questionnaire where 
having >3 positive answers may indicate an undiagnosed OSA airway pattern.  There is a 
positive correlation between the number of questions answered positively and the severity of the 
OSA (Seet & Chung, 2010).  Researchers using the tool in the peri-anesthetic setting have 
demonstrated mixed results.  Since it has been demonstrated to be useful in categorizing risk for 
OSA, it will be used in this research study.  To improve uniformity in categorizing OSA risk, the 
STOP-Bang questionnaire will be administered in the perioperative setting. 
OSA in the Perioperative Setting 
 Patients with OSA may have higher pre-existing CO2 levels, increasing their sensitivity 
to medications commonly administered in the perioperative setting, elevating their risk of apnea 
and other adverse respiratory events (Liao et al., 2009).  Opioids, benzodiazepines, and other 
common perioperative medications administered for anxiety and pain management attenuate the 
central nervous system's (CNS) response to circulating CO2.  Recumbent positioning can further 
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exacerbate the problem of reduced and obstructed airflow (Jordan et al., 2014).  By nature of the 
obstructive process, there is a need for nurses to detect changes in ventilatory status and 
intervene promptly.  If unrecognized, patients with OSA pose a higher risk of decompensating, 
requiring emergency interventions to support ventilation.   
 The anatomic and physiological changes to airway structures and respiratory patterns 
associated with OSA should be of concern for nurses and anesthesia providers who care for these 
patients, especially in the perioperative setting (Gammon & Ricker, 2012).  Patients who 
undergo monitored anesthesia care sedation, regional, or general anesthesia receive anxiolytics, 
potent opioid narcotics, antihistamines, and other anesthetic adjuncts.  The CNS changes 
associated with these medications can increase respiratory depression severity, reduce CNS 
stimulation to the genioglossus dilator muscles, and alter REM sleep patterns (Chung, et. al., 
2014).   
 In the operating room, anesthesia providers use pulse oximetry, which measures 
hemoglobin saturation of oxygen (SpO2), capnography, mechanical ventilation, and occasionally 
arterial blood gas analyses to guide ventilation and oxygenation status (Allan Klock, Anderson, 
& Hernandez, 2017).  Anesthesia providers use these monitors help in identifying obstructed 
airflow patterns to make appropriate interventions, improving ventilatory and oxygenation 
patterns.  Upon entry to the postoperative anesthesia care units (PACU), qualified registered 
nurses typically receive reports regarding the anesthetic and intraoperative events (Robins & Dai, 
2015) and begin assessing patients.  Monitors for ECG, blood pressure, and oxygenation status 
are reapplied, and vital signs are examined.  Without specific monitors to help guide clinical 
decisions, inaccurate assessments and treatments can be administered.  Capnography and 
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mechanical ventilation are not routinely used in the PACU setting making early detection of an 
impaired airway more difficult. 
Postoperative Management Standards for OSA Patients 
 After surgery, patients undergo recovery in a designated PACU where nurses monitor 
and identify changes in patients' status, follow written postoperative orders, and make decisions 
to notify anesthesia providers to make interventions (Whitaker et al., 2013).  Routine monitoring 
of airway and ventilatory status, pain level, hemodynamics, and hydration may be insufficient 
when patients with OSA arrive in PACUs after receiving anesthesia.  Society of Anesthesia and 
Sleep Medicine has recently published (Chung et al., 2016) and updated practice 
recommendations for screening and management of patients with OSA.  Additional guidelines 
have been published including checklists specifically for anesthesia providers and perioperative 
nurses to assess and manage outcomes (Butterworth, Mackey, & Wasnick, 2013; Gammon & 
Ricker, 2012). 
 Standard monitors include pulse oximetry, ECG, and noninvasive or arterial blood 
pressure monitors (NIBP or ABP respectively).  Anesthesia providers and PACU registered 
nurses (RNs) use data from these monitors coupled with assessment skills to evaluate patient's 
physiological status, level of arousal, and severity of pain.  Before moving from the PACU to a 
less intensely monitored area, patients must meet discharge readiness criteria.  PACU nurses 
follow standardized checklists approved for their postoperative setting.  The Modified Aldrete 
Scoring Tool (Appendix D) is a common instrument used to evaluate discharge readiness; 
patients must meet a score of >9/10 (Hadzic et al., 2005).  The tool measures a patient’s 
"activity, respiration, circulation, consciousness, and oxygen saturation" (Butterworth, Mackey, 
& Wasnick, 2013), deriving a 0, 1, or 2 rating for each parameter with a composite score totaling 
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up to 10.  Additional criteria for discharge may require a set time in PACU to be met (typically 
45 minutes after a general anesthetic) depending on the procedure and type of anesthetic 
administered.  
Monitors and the OSA Patient  
 Difficulties can arise when patients are admitted to the PACU with co-morbidities such 
as OSA, that challenge the nurse’s ability to make accurate and timely clinical decisions (Moos 
et al., 2005).  Selection and use of appropriate monitors support a nurse's ability to recognize 
changes, deter complications, and reduce morbidity (Tweddell, Ghanayem, & Hoffman, 2014).  
Current respiratory monitoring devices used in PACUs lack a high degree of sensitivity and may 
underestimate patients’ ventilatory status even when applied appropriately. 
 Traditional monitoring techniques are prone to sampling error and are indirect or delayed 
measurements of ventilation status.  New instruments that are statistically and clinically valid 
and reliable are needed to detect hypoventilation events (Voscopoulos, Brayanov, Ladd, Lalli, 
Panasyuk, & Freeman, 2013).  
ExSpironTM Monitor and OSA  
 The ExSpironTM is a FDA approved respiratory ventilation monitor (RVM) that measures 
chest movement through variations in impedance and continuously identifies respiratory patterns 
(Voscopoulus et al, 2013; Schumann et al., 2016).  Respiratory rate (RR) and tidal volume (TV) 
are measured, and minute ventilation (MV) is calculated.  The RVM has the potential to identify 
inadequate ventilatory patterns in patients, thus alerting healthcare providers to make timely 
interventions that may reduce the incidence of postoperative complications.  Use of the RVM in 
the perioperative setting has been limited, but promising.  Previous studies using the RVM have 
measured postoperative hypoventilation and apneic events in morbidly obese patients (Schumann 
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et al., 2016), the effects of opioids on ventilation in patients after orthopedic surgery (Fleming et 
al., 2015), and ventilatory changes in patients who have received intravenous sedation (Holley, 
MacNabb, Georgiadis, Minasyan, Shukla, & Mathews, 2016).  
 While Schumann et al. (2016) used the RVM to monitor obese patients for occurrences of 
postoperative hypoventilation and apnea, they did not explore the relationship to pulse oximetry 
data, nor measure the ventilatory changes when respiratory interventions (including NPPV) were 
used postoperatively.  ExSpiron™ technology may give clinicians an additional layer of 
information beyond oximetry and capnography (Voscopoulos et al., 2013).  These relationships 
have not been explored.  Because research is lacking these areas, the ExSpironTM will be used in 
this research study to monitor postoperative ventilatory patterns in the OSA surgical population.  
The PI will use data obtained from the RVM to: 1.) Record ventilatory changes and correlate 
those changes to coinciding pulse oximetry data.  2.) Measure changes in ventilation when NPPV 
is used or discontinued.  3.) Explore the relationship between screened OSA severity and 
occurrences of respiratory depression in the PACU.  4.) Explore relationships between patients 
who have a formal diagnosis of OSA to those who do not, including the occurrence of 
respiratory depression in the PACU. 
The Role of Postoperative CPAP Therapy  
 The primary therapy after diagnosis of moderate and severe OSA is application of a 
NPPV. Typically this is a CPAP or Bi-level auto-titrated positive pressure (BiPAP) mask 
(Antonescu-Turcu & Parthasarathy, 2010; Brousseau, Dobson, & Milne, 2014).  At the 
institution where this study will be taking place, patients who use a NPPV (CPAP/BiPAP) mask 
at home are instructed to bring their mask and machine to the hospital on the day of surgery.  The 
mask may be used postoperatively to assist in ventilation, especially in the patient's room while 
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they are sleeping.  Kohler, Smith, Tippett, and Stradling (2010) noted from prior studies that 
home CPAP use for just 3.5-4 hours nightly improves subjective sleepiness and attenuates 
cardiovascular effects of OSA.  Patients with OSA who wear a NPPV mask at least 4 hours night 
are considered to be compliant with using the therapy.  Because of the airway changes associated 
with OSA and the compounding effects perioperative mediations may have on the airway, a 
NPPV device should be available for every patient with OSA.  
 Postoperative application of NPPV as a respiratory intervention is typically initiated after 
other interventions (positioning, oxygen therapy, and physical/verbal stimuli) are used to 
maintain oxygenation and ventilation.  A clinical limitation of NPPV use is the nurses’ 
inexperience with mask application.  This may result in inappropriate application and 
ineffectiveness.  A lack of standardized orders (Gross et al., 2014) for timing and duration of 
NPPV, and patient unfamiliarity with the treatment may also limit the benefits of this therapy. 
Patients with OSA who are not diagnosed preoperatively may resist postoperative application 
due to discomfort (Paje & Kremer, 2006) and irritation.  Therefore, preoperative screening and 
patient and healthcare provider education are required (Porhomayon, Zadeii, Nader, Bancroft, & 
Yarahamadi, 2013) if this treatment is to be successful.  
Statement of the Problems 
 Noninvasive measurements of postoperative ventilatory values of patients with OSA have 
been limited.  Thus, the ability of a PACU nurse to make judicious clinical decisions regarding a 
patient’s status is confined to clinical experience, knowledge, and the use of current monitoring 
instruments.   
 There are numerous ways to measure perioperative oxygenation and ventilation status.  
Pulse oximetry is an indirect measurement of ventilation status, and SpO2 recordings can be 
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misleading when supplemental oxygen is used (Fu, Downs, Schweiger, Miguel, & Smith, 2004; 
Sivilotti, Messenger, van Vlymen, Dungey, & Murray, 2010).  Arterial blood gas (ABG) 
provides an accurate assessment of ventilation, oxygenation, and metabolic demands, but is 
invasive, costly, and requires an arterial blood sample to run the analyses (Allan Klock et al., 
2017).  Capnography in the extubated patient provides excellent respiratory rate information 
(Gaucher, Frasca, Mimoz, & Debaene, 2012), but actual exhaled CO2 partial pressures are prone 
to sampling error, especially with high supplemental oxygen flow rates, making it difficult to 
interpret values when devices are not placed in a closed system (e.g., endotracheal intubation).   
 To help overcome these measurement limitations of postoperative ventilatory status, a 
non-invasive impedance device, the ExSpironTM Respiratory Volume Monitor (RVM) will be 
included with the existing monitors.  The instrument measures tidal volumes and respiratory 
patterns, and calculates minute ventilation (Voscopoulos et al. 2013; Voscopoulos, MacNabb, 
Freeman, Galvagno, Ladd, & George, 2014).  The monitor provides measurements of MV 
independent of supplemental oxygenation, use of facemasks, or peripheral tissue perfusion issues 
that can compromise other instruments/measurements.   
 Schumann et al. (2016) assessed the accuracy of the RVM in obese surgical patients.  
They synchronized the RVM intraoperatively and found the RVM to be very accurate.  It had 
only a 0.13L/min measurement error and correlation of r = 0.89 against the ventilator data.  The 
RVM can deliver continuous data on postoperative ventilation status providing feedback to the 
practitioner and the capability of alerting healthcare providers when inadequate ventilation is 
detected.  Default limits are set to notify providers when MV volumes fall below 40 percent of 
the patients predicted MV (Pred 40%).  The monitor has been successfully used in the 
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perioperative setting assessing postoperative respiratory depression in an obese surgical 
population (Schumann et al., 2016).  
 Current postoperative monitors for assessing patients recovering from anesthesia provide 
beneficial information but have limitations.  In the postoperative patient with OSA, standardized 
monitoring and assessment techniques may be insufficient identifying early changes in 
ventilation status before respiratory decompensation occurs.  Finally, there is a gap in the 
literature regarding ventilatory responses (MV, TV) associated with NPPV application in the 
PACU setting.  Having real-time feedback on ventilatory changes including the effects of NPPV 
in the PACU may increase our understanding of the benefits of NPPV devices in patients with 
obstructive airflow patterns.  Recognition of ineffective ventilation before it becomes severely 
limited may lead to timely interventions to help increase gas exchange and attenuate the negative 
effects of obstructive airflow.  Through implementing NPPV or other interventions, OSA 
patients may have improved ventilation and oxygenation, be more alert, and have reduced 
recovery times.   
Conceptual Framework 
 The conceptual framework for respiratory ventilation patterns in OSA patients was 
depicted in figure 1 (Jordan et al., 2003).  Grippi et al. (2015) noted the effects of sustained OSA 
ventilation patterns on various physiological processes.  This physiological cycle is important to 
identify in any patient undergoing surgery.  For those predisposed to obstructive airflow patterns 
(older, obese, male gender, larger neck circumferences) more sensitive instruments may be 
needed to determine when there is a reduction or cessation in airflow.  A model noting the 
identification and attenuation of obstructed airflow is proposed (figure 2).  As nurses are alerted 
to ventilatory alterations (signal from RVM) and nursing interventions (position changes, 
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verbal/tactile stimuli, NPPV therapy) are initiated, the airway can reestablish patency allowing 
for gas exchange.  The net effects in the PACU setting include reduced CO2 retention, a more 
awake/alert patient that can participate in their recovery process, and are ready for discharge 
earlier.  If hypoventilatory states are missed, or not detected, worsening of ventilation may ensue 
requiring more invasive interventions and may lead to worse outcomes.  The purpose for this 
study is to determine if obstructed airflow patterns correlate with OSA severity, and if these 
alterations are identified with the RVM before other standard monitors detect 
hypoventilation/obstructed respiratory patterns.  The effects of CPAP therapy as an intervention 
will be measured directly with the ExSpironTM monitor to demonstrate the reversal of impeded 
airflow with positive airway pressure. 
 
 
Figure 2: A conceptual model depicting identification of postoperative ventilatory changes. 

































 The central purpose is the appropriate identification of obstructed airflow patterns as 
demonstrated by hypoventilation or apneic breathing.  As hypoventilation or obstructed patterns 
are identified and interventions are performed (CPAP application), the patient’s CO2 levels can 
be reduced. PaO2 can increase and the airway becomes more open.  This will improve ventilation 
and thereby gas exchange.  The overall effect is improved level of alertness and overall minute 
ventilation, reduced PACU stay, and improved patient outcomes.  If hypoventilation detection is 
missed or delayed, it is hypothesized that worsening airflow/obstructive patterns will ensue, 
increasing the patient’s CO2 levels and reducing oxygen to the tissues.  The overall effects lead 
to delayed recovery, more aggressive interventions to regain a patent airway, and potential 
worsening patient outcomes.   
 The proposed research is intended to increase understanding of clinical data an RVM 
provides.  By measuring minute ventilation, alterations in minute ventilation may be detected 
earlier than with standard monitoring devices to improve outcomes.  Additionally, data will be 
correlated with OSA severity when NPPV is used in the postoperative setting. 
Research Questions 
 Three research questions will guide the research study to address knowledge gaps 
regarding the effects of OSA on post-surgical patients and the role of NPPV application on their 
minute ventilation.  The proposed study design will be a prospective observational correlational 
study of patients with known or suspected OSA, recovering gastric bypass surgery (GBS) (Roux 
en-Y or gastric sleeve) in the PACU of a major medical center in the eastern United States.  The 
researcher will address the following questions: 
1. Is there a difference in pulse oximetry recordings, respiratory rates, minute ventilation 
(MV) patterns, and PACU length of stay between OSA severity groups (mild vs. 
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moderate/severe), OSA history groups (previously diagnosed vs. no formal diagnosis), or 
NPPV use groups (NPPV vs. non-NPPV) as measured by the STOP-Bang and 
preoperative evaluation questionnaires? 
2. What is the association of pulse oximetry recordings to respiratory parameters (TV, RR, 
MV) measured by the RVM?  
a. Which monitor identifies changes in respiratory parameters earlier (SpO2 
recording 90-92% (moderate hypoxemia) lasting ≥1 minute while on oxygen at 2-
4 liters/minute or a drop in a SpO2 recording ≥4% from baseline lasting ≥1 minute 
when no supplemental oxygen is used vs. RVM recording of a MV < pred40% 
(moderate hypoventilation)), and is the detection time difference significant? 
b. When the RVM detects hypoventilation (MV < pred40%) or apnea events (no 
detected RR >10 seconds), are there associated changes in pulse oximetry (SpO2 
< 92% when on oxygen 2-4 liters/min or drop in SpO2 ≥4% from the preoperative 
SpO2 lasting ≥1 minute when no supplemental oxygen is used)? 
3. How does NPPV application affect MV (TV and RR)? 
a. When NPPV is applied or removed, what are the MV volumes at 1, 5, and 15 
minutes of use and/or removal, and is the volume change significant? 
b. Is there a significant difference in the number of respiratory events (any recorded 
MV < pred40% value; any SpO2 recording <92% lasting ≥1 minute while on 
oxygen at 2-4 liters/minute, or any drop in SpO2 ≥4% from the preoperative SpO2 
recording lasting ≥1 minute when no supplemental oxygen is used) between 





 Future management of OSA requires additional research to identify specific outcomes of 
interventions provided in the perioperative setting.  Gaps in research include: 1.) Determining 
best methods for assessing for changes in ventilatory patterns in patients suspected of or 
diagnosed with OSA. 2.) Understanding and/or anticipating patient variability and response to 
interventions and medications. 3) Identifying and developing specific practice standards for 
screening, monitoring, and managing patients with OSA.  It is intended that this dissertation will 
demonstrate that an alternative method for monitoring ventilatory status in the PACU setting is 
effective for patients that are at a higher risk for postoperative ventilatory disturbances and that 
NPPV responsiveness may be measured directly to help guide additional postoperative therapies. 
 Five chapters compose this dissertation.  Chapter 1 is the introduction and overview of 
OSA significance and perioperative management, theoretical framework of OSA ventilation 
patterns, and plans to explore research gaps of knowledge.  Chapter 2 is the literature review of 
OSA severity and screening tools, current postoperative monitoring methods for ventilation 
patterns, and use of positive pressure airway devices as a supportive therapy.  Chapter 3 
describes the research methodology and proposed study.  Chapter 4 is the results and data 
summaries, analyses, and interpretation of data.  Chapter 5 is the concluding remarks and 
recommendations for solutions and additional research.   
Definitions 
Obstructive sleep apnea (OSA) is the physiological effect of reduced or obstructed airflow from 
collapsed posterior pharyngeal structures when simultaneous chest/abdominal exertions are 
noted (Cropsey & McEvoy, 2017; Moos et al., 2005).  Symptomology may include snoring, 
gasping, nocturnal awakenings and disrupted sleep, increasing daytime sleepiness, weight gain, 
and a lack of energy.  Physiological characteristics associated with increased OSA risk include 
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hypertension, male gender, and large neck circumference.  Obstructive breathing patterns are 
measured and reported as an AHI index determining the events per hour, and correlating those to 
severity of OSA (Chung et al., 2016).  Subjective assessments of severity will be scored using 
the STOP-Bang questionnaire with 1-3 yes questions categorized as mild, and >4 yes questions 
categorized as moderate/severe OSA (Seet & Chung, 2010; Schumann et al., 2016). 
Hypopnea and apnea is a reduction (>50%) or cessation (>90%) of airflow in during sleep from 
the closure of the posterior pharyngeal dilator muscles despite the musculoskeletal effort of the 
diaphragm or chest wall.  OSA is defined by "an apnea-hypopnea index (AHI) of 5 or greater" 
Chung et al., 2014, p. 287).  
Apneustic-hypopnea index (AHI) is the score given after a polysomnography sleep study 
calculated by measuring and averaging the hourly apneustic and hypopnea events per hour of 
sleep.  There is a negative correlation: A higher AHI score correlates with a worsening OSA 
severity.  AHI scores will be collected from the participant’s electronic health record when 
applicable. 
Non-invasive positive pressure ventilation (NPPV) can include any device applied to the mouth 
and/or nose to provide continuous or intermittent positive airway pressure to aid in dilating the 
hypopharyngeal structures and/or support ventilation.  Devices include continuous positive 
airway pressure (CPAP) masks and intermittent positive pressure masks, typically bi-level 
positive pressure (BiPAP) masks or nasal prongs (Masa et al., 2015).  Pressure settings will be 
collected from all participants who use CPAP/BiPAP at home. 
Bi-level positive pressure (BiPAP) is a type of noninvasive ventilation device used to both stent 
open an obstructed airway and provide positive pressure to improve ventilation by increasing 
tidal volume.  Settings are in cm H2O and are adjustable.  The higher pressure assists in 
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ventilation while the lower is set to stent the airway open.  Both pressures are used in tandem to 
increase the depth of ventilation and open obstructive airways.  
Continuous positive airway pressure (CPAP) is an airway device used to stent open an 
obstructed airway to reduce the collapsibility of the pharyngeal structures.  CPAP devices 
include home or hospital designated devices.  In the perioperative setting a disposable CPAP 
device is available (Boussignac CPAP) that provides CPAP at 5cm H2O or 10 cm H2O when 
corresponding oxygen flows are at 15 or 25 liters/minute. 
NPPV compliance is the adherence of the participant to wearing a home pressure support mask 
to attenuate obstructive airflow patterns while asleep.  Compliance will be noted “yes” if the 
participant is consistently wearing the mask >4 hours/night for three weeks prior to surgery. 
NPPV application is the time and duration of NPPV use during the postoperative recovery 
period.  The initiation, duration, and completion times of NPPV use will be extracted from the 
participant’s document flow sheet.   
Minute ventilation (MV) is volume of gas exchanged through breathing in and out per minute 
time.  MV is calculated using the following formula: (MV= respiratory rate x tidal volume), and 
reported in liters/minute.  MV will be calculated by the ExSpironTM RVM from the continuous 
data collected of respiratory rates (RR) and tidal volumes (TV) calibrated against the anesthesia 
ventilator. 
Mean minute ventilation is the average MV recorded during the PACU admission obtained from 
the RVM and matched to the patient record.  Mean minute ventilation from the RVM monitor 
will be recorded at one and five minute intervals to calculate overall mean MV.  
Hypoventilation is described as any period of inadequate gas exchange causing retention of CO2. 
Common causes are respiratory depression from opioids, residual anesthetics or hypnotic agents, 
22	
	
airway obstructions or blockages, or any airway edema developing insufficient gas exchange 
(Allan Klock et al. 2017).  Hypoventilation will be recorded when any minute ventilation data 
point measured is less than 40% of the predicted MV volume (pred40%) calculated from the 
participants gender, height, and weight (Voscopoulos et al., 2014).  
Respiratory Events are observed or recorded adverse changes in MV or oxygenation during the 
PACU recovery period.  A respiratory event will include any recorded MV < pred40% value, any 
SpO2 recording <92% lasting >1 minute while on oxygen at 2-4 liters/minute, or any drop in 
SpO2 ≥4% from the preoperative SpO2 value lasting ≥1 minute when no supplemental oxygen is 
used. 
PACU Time is overall time required for the patient to stabilize and meet discharge criteria set for 
patients in the PACU setting.  This includes, having regular breathing patterns, stable 
hemodynamic readings, tolerable pain levels, and being able to protect their airway from 
obstruction and aspiration.  PACU time is measured in minutes.  It starts at PACU admission and 
ends when the patient has a Modified Aldrete Score ≥9/10. PACU RNs record these time events 
in the documentation flow sheet (Hadzic et al., 2005). 
	
	
CHAPTER 2: REVIEW OF THE LITERATURE 
 
	 Much has been published in health professional journals about the impact of OSA on 
quality of life, healthcare management, as well as strategies to identify and manage patients with 
this diagnosis.  Different expert professional organizations have conducted literature reviews to 
better understand screening, monitoring, and management strategies to reduce negative outcomes 
of patients with OSA in the perioperative setting.  Research has demonstrated higher costs both 
in dollars and time, as well as increases in perioperative morbidity and mortality.  However, 
there remains a lack of standardized approaches to screening, managing, and monitoring OSA in 
the perioperative setting.  General guidelines have been suggested but practitioners and health 
systems remain responsible for individual acceptance and implementation of treatment strategies. 
 The purpose of this literature review is first, to review polysomnography as an OSA 
evaluation standard.  Second, to evaluate the STOP-Bang questionnaire (SBQ) as an assessment 
tool for identifying OSA risk severity, and its potential usefulness in this research study.   
 The third objective is to review typical monitors used to monitor patients with OSA in the 
PACU.  This will be followed by a review of a new machine called the ExSpironTM.  It is an 
innovative impedance respiratory volume monitor (RVM) that directly measures respiratory rates 
and calculates ventilation patterns.  
 The final aspect of this review of literature is to examine the role of non-invasive positive 
pressure ventilation (NPPV) and its effects on postoperative ventilation.  Several types of NPPV 
are available for use by patients in the home setting. These include CPAP and BiPAP full-face 
and nasal prong masks.  NPPV is often used as an intervention for those diagnosed with 
moderate or severe OSA determined by PSG.  It seems appropriate that healthcare providers 
would understand the function and use of NPPV in order to determine when the therapy is 
24	
	
working effectively.  The use of postoperative NPPV therapy will be reviewed to identify the 
possible benefits of this therapy.  The analysis of the literature will conclude with thoughts 
regarding the three focused areas and their relationship to the research proposal questions and 
design. 
Preoperative Screening for OSA 
OSA Screening 
  Literature suggests the importance of identification of OSA through screening tools.  The 
"gold standard" is a polysomnography (PSG) sleep study that provides an apneustic/hypopnea 
index (AHI) (Abrishami, et al., 2010; Boese, et al., 2014; Chung et al., 2014).  The averaged 
events per hour of sleep determine the AHI, with higher averaged events indicating greater OSA 
severity.  An AHI ≥5 is a diagnostic result of the PSG for OSA.  Screening for severity is 
determined as mild, moderate, or severe with corresponding averaged AHIs of 5-15, 15-30, >30 
events/hour (Chung et al., 2016) confirmed by a sleep medicine physician.  AHI score is often 
correlated with results from OSA questionnaires when available. 
 Individuals with moderate and severe OSA are often treated with NPPV.  This requires 
proper fitting of a nasal or a full-face mask (CPAP or BiPAP) to assist in maintaining a patent 
hypopharynx, improving airflow during sleep.  A second sleep test is then conducted to fit-test 
the mask and adjust pressure settings to open the closed airway, attenuate obstructive airflow, 
and improve sleep.  The test, performed in an overnight sleep lab or with a home portable unit is 
the standard measurement tool for determining OSA severity.  Limitations of PSG sleep studies 
include cost, time commitment, and participants willing to attend sleep studies and be compliant 
with wearing the NPPV device.  
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  For those not participating in a sleep study, several types of screening questionnaires are 
available for diagnosing OSA severity (Chiu, et al., 2016; Chung et al., 2008; Dimitrov, & 
Macavei, 2016; Finkel et al., 2009; Wolfe, Pomerantz, Miller, Weiss-Coleman, & Solomonides, 
2016), and identifying patients with potential airway problems (Abrishami et al., 2010; Chung, et 
al., 2014; Seet & Chung, 2010).  The questionnaires assign risk of OSA and/or OSA severity 
based on responses and clinical measures obtained from participants.  The results if utilized 
during preoperative evaluation may alert anesthesia providers of potential complications prior to 
surgery.  Despite the usefulness and ease of the screening tools, no national standard for adopting 
or implementing them exist, leaving institutions to decide their best practice strategies.  
Additionally, screening tools available have variable degrees of sensitivity and specificity for 
predicting OSA (Chiu et al., 2016; Dimitrov, & Macavei, 2016).  Most however have been 
validated against formal PSG.  The STOP-Bang questionnaire (SBQ) has demonstrated an 
increased level of sensitivity in predicting moderate to severe OSA, when compared to the 
STOP, Berlin Questionnaire (BQ), and Epworth Sleepiness Scales (ESS) (Chui et al., 2016). 
The STOP-Bang Questionnaire 
 The SBQ is one of the most commonly used preoperative screening tools for predicting 
OSA (Appendix C) (Seet & Chung, 2010).  The eight-item instrument was developed by Chung 
et al. (2008) and based on similar questions to the BQ.  The four initial questions comprised the 
STOP portion of the questionnaire.  All questions accompany yes/no responses; with patients 
responding to ≥2 STOP questions with a “yes” are suggestive of having moderate OSA severity.   
 The tool was validated using patients from preoperative clinics in two metropolitan 
hospitals.  A total of 2721 participants completed the STOP and BQ screening questionnaires for 
factor analysis of the 14 screened items.  Researchers noted four factors comprised >95% of the 
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eigenvalues, having a loading factor greater than 0.3 (Chung et al., 2008).  Pilot test results 
identified 27.5% of patients (679 of 2,467) as being at “high risk” of having OSA.  Participants 
underwent PSG studies to validate the STOP questionnaire, with 177 (pilot and validation study) 
participants completing the STOP questionnaire and PSG study.  Researchers used AHI ≥5 as an 
OSA diagnosis and found 122 patients with OSA: 52 (29.4%) mild, 31(17.5%) moderate, and 39 
(22.0 %) severe.  Predictive parameters demonstrated the STOP score as having a sensitivity of 
66%, specificity 60%, Positive Predictive Value (PPV) of 78% and Negative Predictive Value 
(NPV) of 44%.  Sensitivity and NPV increased with comparative OSA severity screened with 
overnight PSG.  
 During a secondary analysis of individual parameters among different patient 
populations, Chung et al. (2008) noted four factors increased the predictive ability of the tool to 
detect moderate and severe OSA.  These four additional factors included a BMI >35kg/m2, age 
>50 years, male gender, and a neck circumference > 40cm.  Four questions were added to the 
STOP tool to form the STOP-Bang questionnaire.  Researchers then adopted the STOP-Bang 
screening questionnaire to increase tool’s sensitivity in predicting moderate to severe OSA risk.  
 Clinical benefits of this tool are ease of use, minimal time to complete the questionnaire, 
having only eight yes/no questions, and one measurement to be accomplished (Chung et al. 
2008; Chung et al., 2012).  Limitations include the importance of the participant and/or family 
members to understand and answer questions.  Dimitrov and Macavei (2016) suggested that 
participants answering or having ≥3 “yes” responses to the STOP-Bang questionnaire may 
indicate an underlying undiagnosed OSA airway pattern.  Suggestive OSA severity increases as 
more questions are answered "yes", increasing the sensitivity for predicting mild, moderate, or 




 Additional research has been conducted to further validate the utility of the SBQ. 
Researchers have used the SBQ to screen for OSA severity, compare results against PSG and/or 
other questionnaires, and correlate screened risk to perioperative outcomes.  The SBQ has been 
used in research, including patient populations undergoing CABG vs. abdominal (Nunes, Danzi-
Soares, Genta, Drager, Cesar, & Lorenzi-Filho, 2016), gynecologic oncology (Bamgbade, Khaw, 
Sawati, & Holland, 2016), emergency (Chudeau et al., 2016), and bariatric surgeries (Proczko, et 
al., 2014; Schumann et al., 2016).  Systematic reviews (Dimitrov & Macavei, 2016; Nagappa et 
al., 2015) and a meta-analysis (Chiu et al., 2016) have further validated the benefits of using the 
SBQ in screening patients for OSA severity.  
 Dimitrov and Macavei’s (2016) review included 12 studies with varying sample sizes (n= 
61-5342).  Studies (10 case-cohort, 2 case-control, 7 retrospective, 5-prospective) categorized 
OSA risk high vs. low as a SBQ of ≥3 or ≤3 respectively.  A SBQ ≥ 3 was associated with longer 
lengths of PACU stay, larger neck circumferences, difficulties with ventilation and/or 
intubations, and a higher likelihood of patients experiencing postoperative hypoxemia events 
(9% vs. 3%, p = 0.012).  Nagappa et al. (2015) reviewed 17 studies (n= 9206) using SBQ.  These 
studies correlated PSG with AHI ≥5 or respiratory desaturation index (RDI) ≥5.  Researchers 
noted their review was limited.  Most of the studies involved only sleep labs and few surgical 
populations were included.  Overall pooled SBQ sensitivity was 94% in sleep labs and 91% in 
surgical populations when SBQ of ≥3 was used as cut-off criteria.  Researchers identified three 
additional factors important to identify with patients at risk of OSA when the SBQ is ≥2.  These 
included a “yes” response to questions: male gender, BMI >35kg/m2, and neck circumference 
>40cm.  For patients who have only a few “yes” responses to the SBQ, a serum bicarbonate level 
>28 mmol/dl may indicate a high OSA risk.  
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 Fernandez-Bustamante et al. (2017) retrospectively reviewed perioperative adverse 
respiratory events when screened by the SBQ.  They found those who were not previously 
identified but screened and/or suggestive of being OSA positive (5.3%) had similar rates of 
adverse respiratory events (AREs) as those previously diagnosed (11.9%).  However, they 
required additional respiratory interventions, hospital resources, an increased length of hospital 
stay, and had higher all-cause 30-day mortality.  Researchers suggested participants may benefit 
from additional medical care and focused strategies to monitor and prevent AREs.  
 Xara, Mendonca, Pereira, Santos, and Abelha (2015) performed a matched-pairs study to 
identify AREs after general anesthesia in patients who had SBQ >3 vs. <3.  Fifty-nine matched 
pairs were observed.  The high-risk OSA group had larger BMIs, more gastric bypass 
procedures, higher incidences of co-morbidities, and significantly more AREs in PACU (39% vs. 
9%, p =0.001).  Of note, more patients designated as “high-risk” had difficulties breathing 
deeply, and increased mild to moderate hypoxia incidents.  Researchers used moderate and 
severe hypoxemia cut-off values of SpO2 readings (93%-90% or <90% on 3 liters of nasal 
cannula O2 respectively) to correlate AREs with OSA severity.  
 Gokay, Tastan, and Orhan (2016) prospectively compared the BQ to SBQ for evaluating 
potential respiratory complications.  Researchers used oxygen desaturations as one of the 
respiratory complications for comparison.  Oxygen desaturations were defined as period of SpO2 
90-95% for >1minute or <90% for >1 minute when O2 nasal cannula flow was at 4 liters/minute.  
Sample size (n=126) included adults ≥18 years old with ASA physical class I-II undergoing 
cholecystectomy surgery.  Researchers noted that the SBQ tool identified more female patients 
with high-risk OSA than the BQ.  There was a relationship demonstrated between SBQ and the 
incidence of smoking, alcohol consumption, higher BMI scores, age, and male gender.  In 
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contrast, BMI and age were associated factors with high OSA risk when the BQ was used.  Study 
limitations included small sample size, a single institution study site, and inconsistent monitoring 
of respiratory complications after PACU discharge.  Study strengths included participants 
undergoing the same surgical procedure and having the same evaluator in the PACU to identify 
respiratory complications.  Authors suggested using the SBQ as the first-line screening tool for 
OSA risk assessment. 
 Chiu et al’s. (2016) meta-analysis (108 studies) of the SBQ, STOP, BQ, and ESS 
screening instruments reported favorable results for the SBQ.  All studies compared 
questionnaire risk assignment against PSG or RDI’s.  Despite high heterogeneity between the 
studies, there was low publication bias (using Deek’s funnel plots).  Studies were from several 
countries, and included sleep labs, surgical patients, and other populations.  A random effects 
model was used to estimate sensitivity, specificity and diagnostic odds ratios.  Overall the SBQ 
outperformed the other three instruments in detecting mild, moderate, and severe OSA with 
respective pooled sensitivities of 88%, 89%, 93%, with relatedly high response rates.  
Researchers noted limitations of the analysis related to low specificity values, possibly limiting 
the feasibility of the instruments use and increasing the risk of higher false positives, over 
treatment, and wasting resources/personnel. 
STOP-Bang Limitations 
 A few studies have demonstrated that other instruments outperform the SBQ (Deflandre, 
et al., 2017), or were unable to correlate postoperative complications with OSA risk (Bamgbade 
et al., 2016).  Deflandre et al. (2017) compared a new instrument (OSA-50) measuring only 
anthropometric data metrics, reducing subjectivity of answers to the SBQ and other developed 
instruments.  There findings are promising but need additional research and validation.  
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 Schumann and colleagues (2016) prospectively screened bariatric patients undergoing 
gastric bypass or abdominal surgery.  OSA risk scores were assigned and validated against PSG 
when available.  Participants (n =56) screened and assigned OSA risk groups (mild, moderate, or 
severe), had no significant difference in occurrence for postoperative apnea (POA) or 
postoperative respiratory depression (PORD) events.  Overall, respective POA and PORD events 
were found to occur in 31% and 16.3% of participants in the PACU.  A PORD event was noted 
when a measured minute ventilation rate fell below 40% of the predicted minute ventilation (< 
pred40%) value for at least 5 minutes.  A POA event was defined as no detectable breaths noted 
by the respiratory volume monitor (RVM) for > 10 seconds.  POA was determined to be positive 
when >5 apneic events/hour occurred during the PACU period.  Researchers did not report the 
total number of POA or PORD events per patient/OSA group nor correlate pulse oximetry to the 
RVM event data.  This suggests additional research opportunities are available.  A better 
understanding of data healthcare providers receive from postoperative monitors to evaluate 
potential or real AREs should be explored, including which device can consistently alert 
providers to changes in ventilatory patterns.  
STOP-Bang Questionnaire and Research Implications 
 The study findings by Schumann et al. (2016) may help elucidate the limitations of the 
SBQ in associating perioperative risks with the bariatric surgical population and possible 
confines of current PACU monitors.  Despite any validated tool used to predict OSA severity, 
confounding effects of general anesthesia, sedatives, and opioids also exist.  A screening tool can 
assign or predict risk but may not necessarily determine perioperative outcomes.  Additional 
research is needed in bariatric and other surgical populations to further correlate OSA risk to 
postoperative AREs.   
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 Researchers (Subramani, Singh, Wong, Kushida, Malhorta, & Chung, 2017) noted that 
individual OSA phenotypes may exist, including low arousing and high arousing threshold 
phenotypes that may benefit from sedatives (low arousing) or be at higher risk of AREs when 
opioids are administered (high arousing).  Variable responses to changes in CO2 when 
perioperative medications are administered may be seen (Lam, Kunder, Wong, Doufas, & 
Chung, 2016).  Further research is needed to gain additional information into OSA variations as 
they relate to risk assessment and perioperative complications. 
 Most SBQ studies reviewed did not involve both screening/validation of the SBQ and 
correlating assigned risk to clinical outcomes.  Researchers either validated the SBQ against PSG 
alone or in conjunction with other screening tools, or used the SBQ to assign OSA risk groups 
and correlate groups to perioperative events.  Since the SBQ has been validated against PSG in 
many studies over the past 12 years, additional validation against PSG may not be warranted.  
However, Dimitrov and Macavei (2016) suggested additional research is needed in different 
surgical populations and surgical procedures (e.g. bariatric, cardiovascular, orthopedic, and 
general surgeries).  Additional research in this area would be beneficial to stratify patient 
populations requiring more sensitive strategies to identify and prevent AREs.  Despite 
classifying OSA severity and validating against a PSG, there are variations in individual 
responses to general anesthetics, opioids, and sedatives in the perioperative setting.   
 This review supports the utility of the SBQ in the research design.  Participants’ SBQ 
scores will be compared to postoperative respiratory ventilatory patterns as recorded by the 
RVM as was done in Schumann and colleagues (2016) study.  Additionally, the RVM data will 




Postoperative Monitoring Methods for Ventilation Patterns 
 Patients with OSA can be more difficult to assess postoperatively with respect to their 
ventilation and oxygenation.  Application of oxygen may mislead providers into a false sense of 
safety (Sivilotti, et al., 2010).  Relying on and using the appropriate monitor or combination of 
monitors is needed to attenuate potential complications.  Patients with OSA, like all patients, 
recover from the effects of intravenous and/or inhalational anesthetics in the PACU (Whitaker et 
al., 2013).  But with OSA, trapping of gases (CO2, inhaled anesthetics) from recurrent airway 
obstructions has the potential to occur more often.  The obstructed airway coupled with increased 
CNS sensitivity to opioids and sedatives (Lam et al., 2016) may reduce the drive to ventilate, and 
compromise responsiveness.  Subsequently, ensuing acidosis, somnolence, or ultimately an acute 
respiratory event can occur.  Emergency interventions will need to be initiated to stimulate the 
patient’s ventilatory drive, reverse sedative and opioid effects, and reestablish a patent airway.   
 Monitors used to assess changes in hemodynamic status are utilized perioperatively to 
improve patient outcomes, reducing morbidity and mortality.  Monitors and tools specifically for 
assessing/measuring postoperative ventilation and oxygenation will be reviewed.  The 
understanding and appropriate application of these devices aid in alerting healthcare providers to 
identify ventilatory changes and attenuate AREs. 
Current Monitoring Devices 
 Because OSA patients are at a higher risk for respiratory depression, including periods of 
postoperative hypoventilation and apnea, higher levels of vigilance by PACU nurses are needed.  
First and foremost, clinical judgment and immediate observation of the patient by trained 
personnel should never be replaced by technology.  Second, monitors to identify changes in 
ventilatory patterns should be utilized to attenuate respiratory complications.  The tools used to 
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assess and monitor for variability are only as good as the observers understanding and 
appropriate use of them.  Monitors and instruments have been developed to guide clinical 
decisions, provide imminent alarms of changes in physiological status, and provide data to 
confirm and analyze interventions (Applegate et al., 2016; Tweddell et al., 2014). 
 Typical monitors to assess patient’s respiratory function in the PACU are pulse oximetry 
and capnography/end-tidal carbon dioxide (PETCO2).  An invasive assessment of ventilation and 
oxygenation includes arterial blood gas (ABG) analyses, and other blood analyses can assist in 
quantifying respiratory and metabolic changes related to ventilation and oxygenation.  A novel 
noninvasive technique has been developed to calculate minute ventilation through chest wall 
impedance (Voscopoulos et al., 2013) and may provide additional information to help assess for 
ventilatory changes and responses to therapies.  
Pulse Oximetry 
 Pulse oximetry (SpO2) has been utilized for decades in perioperative, in-patient, and 
clinic settings.  This monitor is the primary method of monitoring oxygenation, hypoxia, and 
pulse rate of patients in operating rooms and critical care units.  The probe is disposable or 
reusable and non-invasive.  The device indirectly measures hemoglobin saturation by passing 
two wavelengths of light (660 and 940 nm) through capillary tissue.  Two common types of 
probes use light emitting diodes or reflective oximetry.  They and can be applied over various 
sites, including the nose, ears, fingers, temporal forehead, and feet (Hess & Kacmarek, 2012).  
 Infrared and near infrared wavelengths used in pulse oximetry can produce misleading 
information.  The technology is dependent on blood flow through capillary beds, hemoglobin 
concentration, skin pigmentation, temperature, and movement (Tweddell et al., 2014).  
Historically, failure rate is below 5% (Freund et al., 1991), and increases above this level when a 
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patient’s perfusion is compromised.  This can occur more frequently in elderly, those with ASA 
status ≥3, during prolonged surgical procedures, and after ingestion or inhalation of substances 
that compete with oxygen loading onto the hemoglobin.  
 Inaccurate placement of probes or movement can increase pulse oximetry false-alarm 
rates and may increase alarm burden and missed alarm events (Voepel-Lewis et al., 2013).  The 
addition of oxygen via mask or nasal cannula can overestimate perceived respiratory function 
and is not correlated with end-tidal CO2 levels (Sivilotti et al., 2010).  Comorbidities such as 
OSA may lead to false interpretations of oxygenation and ventilation.  Because of these 
limitations, indirect and incomplete analysis of pulse oximetry can occur, misleading providers 
to make inappropriate clinical decisions.  Additional monitoring devices if implemented in the 
perioperative setting could potentially increase the ability of providers to identify subtle changes 
in ventilation. 
Capnography 
 Capnography, or end-tidal CO2 analysis, provides an additional monitor for ventilation 
assessment and layer of sensitivity in the perioperative setting.  Clinical application of the device 
assists in identifying airway obstruction, esophageal intubation, and hypo/hyperventilatory states.  
Capnography sensitivity is increased when in-line measuring is performed, typically concurrent 
with endotracheal intubation (Sivilotti et al., 2010).  A sample of ventilated gases is obtained 
through a collection line and analyzed by software spectrometry computing the fraction of 
expired CO2.  The data output produces a waveform (capnography) and numerical output in 
millimeters of mercury (mmHg) called capnometry.  Capnography waveform moves along the x-
axis on the screen for analysis.  The waveform elevates from the baseline x-axis with expiration 
of mixed and dead space gases to a plateau phase representing expiration of alveolar gases to a 
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turn toward baseline when inspiration is initiated.  An elevated baseline could represent 
rebreathing or exhausted CO2 absorbent, and an upstroke of the plateau waveform may represent 
an obstructive airway pattern (Hess & Kacmarek, 2012). 
 Capnography and associated capnometry is closely equivalent to partial pressure of 
arterial carbon dioxide (PaCO2) levels in healthy adults, but may be misleading or erroneous 
during ventilation/perfusion (V-Q) mismatches, hypotension, and inadequate ventilation of the 
lungs (e.g. OSA ventilation patterns after extubation) occurs.  The result is an increased PaCO2 
to partial pressure of expired end-tidal carbon dioxide (PETCO2) gradient greater than 3-5mmHg 
(Hess & Kacmarek, 2012).  
 Several other physiological changes in the cardiovascular system can alter capnography 
waveform output and thus affect the interpretation of results.  These include metabolic changes, 
dysrhythmias, pulmonary vascular congestion, hypotension/hypovolemic states, pulmonary 
secretions, alveoli-capillary membrane changes, and obstructive or restrictive respiratory disease 
states.  Despite potential errors from these influences, capnography is a standard monitor used in 
the perioperative environment.  Anesthesia providers routinely use capnography during general 
anesthesia and intravenous sedation cases (Sivilotti et al., 2010).  Capnography is also utilized in 
the PACU setting (Kasuya, Akca, Sessler, Ozaki, & Komatsu, 2009) when warranted.  
 Capnography analyses have been utilized in the postoperative setting when patients are 
admitted with endotracheal or laryngeal mask airway devices in place.  PETCO2 sampling is 
obtained in an in-line fashion and numerical and/or waveform recordings can be measured and 
evaluated.  The added benefit of this monitor is it displays a respiratory waveform and rate 
providing a relatively consistent indication of ventilation status, even with variable oxygen flow 
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(Kasuya et al., 2009).  Despite possible ventilation-to-perfusion (V-Q) mismatch, capnography 
and PETCO2 monitoring provides additional information that may increase patient safety. 
 Anesthesia providers infrequently use capnography in the PACU as most patients are 
extubated prior to admission and direct measurement of expired gases is not possible.  Products 
have now been designed to provide CO2 analysis when patients have an oxygen facemask or 
nasal cannula.  Within these devices, multi-sampling, and micro-stream CO2 sampling ports are 
included to increase accuracy of waveform analysis (Hess & Kacmarek, 2012).  
 Postoperative capnography monitoring may be limited or inadequate in patients with 
OSA.  There is an increased ventilation-to-perfusion (V-Q) mismatch as obesity and OSA 
worsens, and narrowing of small airspaces in the recumbent position becomes more profound.  
Pulmonary changes increase air trapping and airway collapse, and may lead providers to 
underestimate PaCO2 approximations based on observed PETCO2 output.  Additionally, masks 
and cannulas can become clogged with condensation or secretions resulting in inaccurate 
readings.  Home or hospital NPPV masks can irritate patients, and may not be applied 
appropriately when used (Hess & Kacmarek, 2012).  Kasuya et al. (2009) suggested patients who 
are obese and diagnosed OSA positive, should receive postoperative ventilation monitoring using 
capnography that includes an oral sampling port to reduce the PaCO2-PETCO2 gradient.   
ABG Analysis 
 ABG analysis is considered a “gold standard” test, and provides clinicians with accurate 
measurements of patient’s oxygenation and ventilation status.  A patient’s CO2, acidosis, 
bicarbonate, and oxygenation levels can be measured.  This measurement tool is used for 
intraoperative management and assessment of ventilation and perfusion changes in 
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cardiothoracic and other surgical procedures where anesthesia providers are concerned about V-
Q changes, large blood losses, and changes in tissue perfusion and oxygenation.  
 Postoperatively, ABG analysis can be used to quantify the severity of hypoxemia, 
hypoventilation, and V-Q mismatch to help clinicians determine a course of action (Maddox, 
Oglesby, Williams, Fields, & Danello, 2008).  However, ABG analysis comes with a cost, both 
monetarily (as an additional invasive procedure requiring an arterial sampling) and as a use of 
time and additional resources to process the sample.  It does not provide immediate assessment 
of the patient’s status but does deliver a direct evaluation of invasive and noninvasive 
interventions implemented to improve oxygenation, ventilation, and perfusion.   
 ABG analysis as an initial intervention to guide therapy may not be warranted.  See, 
Phua, and Mukhopadhyay, (2009) found no clinically significant differences in ABG analysis 
after extubation in the ICU to help predict those who would require reinstitution of respiratory 
support measures.  Bingol, Pihtili, Cagatay, Okumus, and Kiyan (2015) found no added benefit 
of ABG interpretation when screening for the severity of Obesity Hypoventilation Syndrome in 
patients with OSA.  Instead, the authors found serum bicarbonate ≥ 27 mmol/L with a SpO2 
<80% as predictive screening factors.  Perioperative ABG analysis is useful when available but 
should be reserved as a secondary tool and to corroborate output of less invasive monitors. 
ECG Respiratory Monitoring 
 Respiratory impedance analysis is not new technology.  In the perioperative setting, the 
application of special ECG electrodes that have capabilities to interpret changes in chest wall 
movement can compute and display a respiratory waveform.  Special monitors can be set to 
notify healthcare providers of apneic periods, or where no chest movement is detected 
(Helfenbein, Firoozabadi, Chien, Carlson, & Babaeizadeh, 2014).  A benefit of ECGs with 
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respiratory impedance monitoring is its portability for use in remote locations.  ECG impedance 
monitors are incapable of quantifying the depth and volume of respirations.  Electrodes may 
become dislodged, inappropriately placed, limiting its usefulness.  Patients with OSA commonly 
have higher BMIs increasing the likelihood of altered lead placement limiting the accuracy of 
identifying changes in chest wall movement. 
Respiratory Minute Ventilation Monitor 
 Improving upon the ECG respiratory impedance concept, an innovative instrument has 
been developed. The ExSpiron™ is a FDA approved respiratory volume monitor (RVM) 
developed by Respiratory Motion Inc. (located in Watham, CT).  The RVM continuously 
measures tidal volume and respiratory rates, and calculates a minute ventilation value.  The 
monitor records the data and provides immediate numerical feedback of patients’ ventilatory 
status and plots respiratory patterns on a bedside monitor.  The device may provide an additional 
layer of safety in identifying changes in ventilatory patterns, allowing anesthesia providers and 
PACU nurses to attenuate AREs before they occur.  The RVM may be beneficial in monitoring 
patients with a variety of pulmonary co-morbidities. 
 Special electrodes are placed on the patient’s skin and are connected to a strip that 
attaches to the RVM.  The electrodes are adjustable and can accommodate variable chest girths, 
reducing measurement error in patients with higher BMIs.  This is an advantage over earlier 
ECG impedance devices as described above.  Proper electrode placement for the device is the 
mid-axillary line at the level of the xyphoid and along the sternum forming and L-shape.  The 
RVM has been tested in a variety of clinical settings against calibrated spirometry systems 
monitoring both passive and obstructive respiratory patterns (Voscopoulos et al., 2013).   
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 Once connected to the patient, the RVM is calibrated against a measured ventilation 
value, obtained from either a mechanical ventilator or an oral spirometer with concurrent nasal 
obstruction (Voscopoulos et al., 2013).  Calibration coefficients for each patient are stored in the 
monitoring device itself.  This is advantageous as electrodes can become damaged or require 
temporary removal.  The RVM has the capability of being zeroed to a patient’s baseline 
ventilation rate or calibrated as described above and measured against a known algorithm for 
height, gender, and age.  The non-calibration feature is helpful when a patient undergoes 
sedation or neuraxial anesthesia and a spirometer not available.   
 Williams, George, Harvey, and Freeman (2016) compared the RVM against capnography 
and found while both respiratory rate patterns correlated, the RVM detected changes in 
ventilation patterns earlier than capnography.  Ventilation patterns provided by the RVM give 
more accurate assessment of patients’ ventilatory status and can be used in the extubated patient 
when spirometry cannot be obtained. 
 ExSpiron™ technology apprises healthcare providers with an additional layer of 
information beyond pulse oximetry and capnography.  Point of care information about 
interventions affecting minute ventilation, tidal volume, and respiratory rates can be measured.  
In patients with OSA, researchers (Schumann et al., 2016) found no difference between 
respiratory rate recording and manual counting, and that BMI had no significant effect on the 
accuracy of MV and TV (P >0.6) measurements.  Obstructive breathing patterns were detected 
with this technology and were confirmed against a closed-cell spirometer.  The RVM measured 
artifact “to be in the range of anatomic dead space” providing clinicians with an early warning of 
respiratory obstruction (Voscopoulos et al., 2013, p.7).   
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 Recent clinical applications of the RVM include measuring and quantifying ventilatory 
changes during surgical procedures where hypnotics and opioids are administered.  Effects of 
medications were quantified and subsequent doses adjusted (Ebert, Middleton, & Makhija, 
2015).  The RVM has also been used to measure changes in ventilation in the PACU after opioid 
administration (Voscopoulos et al., 2014).  This has important clinical implications as those who 
develop a reduced MV (below a set threshold) or an obstruction after opioid administration can 
be identified.  Appropriate interventions can then be initiated to improve their ventilatory states.  
The goal is to identify and reduce postoperative respiratory events before PACU discharge.   
 Patients with co-morbidities including OSA, require closer monitoring for changes in 
ventilation.  Earlier detection of ventilatory changes using the RVM may be possible to decrease 
the incidence of perioperative AREs.  The RVM could be used in conjunction with other 
standard monitors, and help provide an immediate assessment of alterations in respiratory rate 
and depth.  The RVM can inform anesthesia providers about subtle changes in ventilation 
patterns.  Providers can then use the data to initiate interventions to reverse respiratory 
depression and obstruction.  Clinical applications in other populations have demonstrated its 
usefulness (Ebert et al., 2015; Holley et al., 2016).  
 Few potential limitations may preclude the use of the RVM.  These include occlusive 
dressings over monitoring sites, and rare allergic reactions to the electrode adhesive.  Fortunately 
electrodes do not to irritate the skin, can be removed, and reapplied (Voscopoulos et al., 2013) 
when needed.  The monitor is portable and can be transported with the patient to various settings 




Instruments to Guide Practice 
 Advances in technology of monitors have allowed clinicians to assimilate information 
and make more informed decisions to guide patient care.  In the PACU setting, there are a 
variety of constraints and pressures affecting patient outcomes.  Patient co-morbidities, staffing 
workload/assignments, clinical experience, and case types all have their toll (Whitaker et al., 
2013; Street et al., 2015) on providing quality and safe care.  The goal of identifying and using 
effective monitors is to determine when, how long, and for what purposes are they applied and 
used (Tweddell et al., 2014).  After a review of articles regarding perioperative monitors, 
specifically for examining respiratory status and for patients with OSA, no clear 
recommendations were found.  The ASA and other perioperative professional organizations 
(Chung et al., 2016) have provided data about the severity of OSA and perioperative strategies to 
screen, manage, and monitor events.  Without specific clinical guidelines, institutions are left to 
formulate their own protocols.   
 Monitoring acute respiratory changes in a deteriorating patient with co-morbidities is 
essential.  Basic monitors should include ECG, non-invasive blood pressure, and pulse oximetry.  
Trained nurses and anesthesia providers should not be substituted for any monitor and all 
personnel must be oriented to and trained to manage patient changes and make timely 
interventions.  The ExSpiron™ could be used on patients prone to respiratory events where 
increased vigilance in monitoring is needed, especially patients with OSA or obstructive airway 
patterns.   
OSA and Newer Monitoring Devices 
 The development of innovative monitors and advanced measuring techniques within the 
last several decades (Sivarajan & Bohn, 2011) has increased patient safety and improved 
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perioperative outcomes (Tweddell et al., 2014).  The increased incidence and impact of OSA in 
the surgical setting (Moos et al., 2005; Schumann, Brayanov, Gupta, & Bonney, 2015) 
necessitates nurses and anesthesia providers to apply current technology with the goal of 
reducing morbidity and unintentional harm.  Including the ExSpiron™ as an additional monitor 
for postoperative nurses may allow for early detection of ventilatory changes and reduce 
potential errors in assessing patients’ respiratory status. 
 The ExSpiron™ provides clinicians in the perioperative setting an opportunity to measure 
and assess both respiratory rate and depth.  This RVM monitor provides an added level of 
information that is independent of the application oxygen.  Pulse oximetry is limited in detecting 
hypoventilation when supplemental oxygen is used, and cannot be used as a measure of 
ventilatory status when oxygen is needed.  Capnography is dependent upon continuous airway 
sampling.  The reliability of this can be compromised by obstruction of sampling lines, rapid 
shallow breathing, and alterations in patient positioning.  The RVM does not have the limitations 
that pulse oximetry and capnography have.  When added to basic monitoring techniques, RVM 
has the ability to detect subtle ventilatory changes in a decompensating patient with or without 
OSA.  This may allow nurses and anesthesia providers to make timely interventions to preclude 
re-intubation, respiratory failure, and unanticipated admission to an ICU.  The RVM should be 
evaluated in other settings and more fully with patients diagnosed with and without OSA to gain 
additional insight into further applications.  Additional benefits may include determining the 
effectiveness and change in ventilation when NPPV (CPAP/BiPAP) support is applied and 




NPPV in the Postoperative Setting 
 NPPV therapy after OSA diagnosis for moderate and severe OSA is the application of a 
CPAP mask or BiPAP mask (Antonescu-Turcu & Parthasarathy, 2010; Brousseau et al., 2014).  
Patients with OSA and using home CPAP/BiPAP are instructed to bring it on the day of surgery.  
Kohler et al. (2010) noted from prior studies that when patients use CPAP at least 3.5-4 hours 
nightly, subjective sleepiness and cardiovascular effects of OSA improve. 
  Postoperative NPPV application is usually secondary to other interventions (positioning, 
oxygen therapy, and physical/verbal stimuli) used to maintain oxygenation and ventilation.  
Other clinical limitations to NPPV effectiveness are a lack of standardized orders for timing and 
duration of application.  Additionally, patients with OSA who are not comfortable with NPPV or 
are undiagnosed formally may resist postoperative application due to discomfort (Paje & 
Kremer, 2006) and irritation.  Therefore preoperative screening and patient and provider 
education is needed (Porhomayon, et al., 2013) if postoperative NPPV is to be a successful 
intervention. 
NPPV Literature Findings 
  Research articles were reviewed regarding the use of NPPV (CPAP or BiPAP) in the 
postoperative setting for patients with OSA.  Eleven articles were identified.  Unique articles, 
including five retrospective studies, four randomized control studies, and two clinical case 
reports were reviewed.  The results of research findings were limited, but promising (Del Campo 
Matias et al., 2008; Liao et al., 2013; Liao et al., 2009; Meng, 2010; Porhomayon et al., 2013; 
Shearer, Magee, Lacasia, Raw, & Kerrigan, 2013).  The review was conducted to investigate 
NPPV use in patients with OSA and postoperative outcome measures used to reduce morbidity 
and mortality.  
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Prospective Research Findings 
 Gaszynski, Tokarz, Piotrowski, & Machala (2007) performed a small randomized 
prospective study (n=19) assigning morbidly obese patients for elective gastric bypass surgery to 
receive CPAP or nasal cannula postoperatively.  They found that CPAP application resulted in 
more alert and better-oxygenated patients compared to the control group, with the control group 
experiencing more oxygen desaturations, and increased work of breathing.  ABG samples were 
obtained at four time intervals for comparison.  Patients who received CPAP had no 
complications related to the positive pressure therapy.  Limitations of the research included small 
sample size, and the fact that CPAP users were allowed to remove their mask up to 30 minutes 
for discomfort.   
 Laio, et al., (2013) conducted a prospective randomized trial (n =100) of patients with 
SBQ ≥3 with a history of OSA who did not use CPAP at home.  Participants with PSG AHI ≥ 15 
were randomized into control and CPAP groups.  Automated positive airway pressure (APAP) 
devices were initiated for overnight use two to three days preoperatively and postoperatively for 
five nights.  Researchers found APAP improved the quality of sleep. APAP users reduced their 
AHI rates from a mean of 30 down to 3 events/hour (p = 0.001), while the control group had no 
improvement in AHI scores (p = 0.302) or desaturation indexes on postoperative day 3.  This is 
significant as the percentage of REM hours can increase postoperatively as sleep interruptions 
and hours of fragmented sleep increase.  APAP users reduced their AHI at postoperative day 3 
indicating a possible benefit of consistent use pre- and post-operative NPPV therapy. 
 Nigelin et al. (2009) prospectively demonstrated the effects of CPAP application using 
the Boussignac CPAP (BCPAP) mask postoperatively in laparoscopic gastric bypass patients (n 
= 40).  The controls group received six-liters/minute nasal cannula oxygen and intervention 
group had the BCPAP mask applied upon extubation.  Oxygen flow at 25 liters/min was used to 
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approximate 10cm H2O CPAP pressure.  BCPAP therapy was paused after one hour to perform 
spirometry testing.  BCPAP was then restarted and continued for the remainder of PACU stay 
and continued on the postoperative night.  A generalized linear model was used for direct 
comparisons and τ-tests at the time point measurements.  Baseline spirometry values were 
comparable.  After the first postoperative hour there were significant differences between groups 
in their spirometry results.  The BCPAP group had clinically and statistically sustained 
preservation of preoperative respiratory function.  They also reported that patients with BCPAP 
application were more alert and had improved FEV1/FVC average scores compared the control 
group. 
 A prospective Canadian study involved bariatric surgical patients >18 to 75 years of age, 
ASA class I-II (n = 81).  Researchers reported that ABG analyses postoperatively were improved 
with BCPAP use compared to patients with venturi mask application (Wong et al., 2011).  They 
also noted improved pulmonary function values and lower titrated oxygen rates in the BCPAP 
without any patient intolerances facemask application.  Pulse oximetry saturations were 
maintained at ≥ 92%.  Strengths of the study included blinding of groups to anesthesia providers, 
and standardized intraoperative anesthetic management.  To increase participants’ compliance 
with the intervention, preoperative education was conducted regarding mask application, 
including potential face and airway irritation from masks and oxygen therapies.  Their study 
limitations included a relatively small sample size and single site study.  Researchers suggested 





CPAP Study Implications 
 In this review of the literature, relatively few prospective studies involving NPPV 
application in the PACU setting were found.  None assessed actual minute ventilation or changes 
in ventilatory patterns as NPPV was applied and/or discontinued.  Researchers provided 
suggestions for future research that included performing additional prospective randomized 
control studies with larger populations, involving multiple case types, and obtaining direct 
measurements of CPAP on minute ventilation during its use.  Chung, Nagappa, Singh, and 
Mokhlesi’s (2016) review of the literature on CPAP use, reconfirmed previous findings.  Some 
of their suggestions included identifying better assessment tools and strategies for identifying 
patients with OSA before they experience respiratory depression, and to conduct studies 
regarding postoperative monitoring procedures. 
 NPPV (CPAP and BiPAP) application will be observed in the postoperative setting.  
Participant’s minute ventilation and oxygen saturations will be measured continuously to identify 
changes in ventilatory status when this intervention is initiated or discontinued.  Previous 
research suggests that ventilatory patterns should improve when NPPV is administered, but the 
discrete changes (percent change, and absolute volumes) have not been studied to date.   
Summary 
 Findings in the literature support the research questions.  OSA severity can be screened 
and categorized as mild, moderate, or severe as measured by the SBQ.  The tool has been widely 
used and is simple to complete in the preoperative setting.  Many studies used a cut off score of 
3-4 to differentiate between moderate and high risk OSA severity (Dimitrov & Macavei, 2016; 
Schumann et al., 2016).  This will facilitate in comparing groups to perioperative outcomes, 
particularly ventilatory patterns including TV, MV, and POA/PORD events.  Standard monitors 
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will be used and recorded on all patients, as is hospital protocol.  These include ECG, pulse 
oximetry, and non-invasive blood pressure to assess for changes in cardiopulmonary status and 
alterations in ventilation and oxygenation.  Desaturation indexes can be identified as a ≥4% 
decrease in baseline oxygenation or SpO2 ≤ 90 or 92% (Fernandez-Bustamante et al., 2017; Xara 
et al., 2015).  The RVM monitor will be used to compare TV, MV, and POA/PORD events 
(Schumann et al., 2016) to pulse oximetry readings and changes associated with use of NPPV, as 
this has not yet been observed.   
 Studies have demonstrated patients benefit from NPPV application (Gaszynski, et al, 
2007; Liao et al., 2013; Nigelan, et al., 2009; & Wong et al., 2011).  Some associated 
improvements include improved oxygenation and ventilation, reduced AHI indexes over time, 
and reduced oxygen desaturation events.  While spirometry has been used to measure changes 
pulmonary function, the test requires patient cooperation, and may be diminished when opioids 
and other medications are administered.  To increase the understanding of the direct effects of 
NPPV therapy on patient’s ventilatory patterns, the RVM will be used postoperatively, as it has 
the ability to continuously measure tidal volumes and respiratory rates, and calculate minute 
ventilation (Voscopoulos et al, 2013; Voscopoulos et al., 2104).  The machine will be calibrated 
to the anesthesia ventilator and be used throughout the PACU period.  The goal is to identify 
ventilatory changes when any type of NPPV therapy is initiated or discontinued to further 
understand the benefits of this intervention.  
 The review of the research identified the potential benefits of implementing a 
standardized tool to identify and assign potential risk in many populations.  But assignment of 
risk does not always correlate with actual patient outcomes.  Innovative instruments such as the 
RVM may provide additional objective data about OSA patients’ ventilatory patterns that may be 
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associated with administration of perioperative medications and NPPV therapy.  Limitations of 
this review include the paucity of current prospective studies of NPPV application in the 




CHAPTER 3: RESEARCH DESIGN 
 
Background/Significance 
 The review of the literature supports further inquiry into postoperative ventilation 
monitoring for obstructive sleep apnea (OSA) patients and understanding the direct effects of 
NPPV (CPAP or BiPAP) therapy.  The purposes of this study were to:  
1. Determine the differences in postoperative ventilation patterns of participants screened 
and categorized by the STOP-Bang Questionnaire (SBQ) as “mild” or “moderate/severe” 
risk for obstructive sleep apnea (OSA).   
2. Determine the correlation of hypoventilation events or apnea events measured by the 
respiratory volume monitor (RVM) versus continuous pulse oximetry recordings (SpO2). 
3. Examine the effects of NPPV (CPAP/BiPAP) application on ventilation status.  
 Using this modality to monitor ventilation, it was theorized that postoperative 
hypoventilation, respiratory depression, and apnea events would be identified earlier than with 
the use of other standard PACU monitors.  This study assessed the effectiveness of the RVM to 
detect and measure ventilatory changes in participants with OSA undergoing bariatric gastric 
bypass surgery.  Participants undergoing gastric bypass surgery (GBS) diagnosed or suspected of 
being OSA positive were used to explore the research questions.  The RVM was used to 
correlate OSA severity risk (from SBQ) to ventilatory changes, pulse oximetry output, and to 
identify changes in ventilatory patterns as NPPV (CPAP/BiPAP) therapy was administered and 
discontinued.  
Research Questions 
1. Is there a difference in pulse oximetry recordings, respiratory rates, minute ventilation 
(MV) patterns, and PACU length of stay between OSA severity groups (mild vs. 
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moderate/severe), OSA history groups (previously diagnosed vs. no formal diagnosis), or 
NPPV use groups (NPPV vs. non-NPPV) as measured by the STOP-Bang and 
preoperative evaluation questionnaires? 
2. What is the association of pulse oximetry recordings to respiratory parameters (TV, RR, 
MV) measured by the RVM?  
a. Which monitor identifies changes in respiratory parameters earlier (SpO2 
recording 90-92% (moderate hypoxemia) lasting ≥1 minute while on oxygen at 2-
4 liters/minute or a drop in a SpO2 recording ≥4% from baseline lasting ≥1 minute 
when no supplemental oxygen is used vs. RVM recording of a MV < pred40% 
(moderate hypoventilation)), and is the detection time difference significant? 
b. When the RVM detects hypoventilation (MV < pred40%) or apnea events (no 
detected RR >10 seconds), are there associated changes in pulse oximetry (SpO2 
< 92% when on oxygen 2-4 liters/min or drop in SpO2 ≥4% from the preoperative 
SpO2 lasting ≥1 minute when no supplemental oxygen is used)? 
3. How does NPPV application affect MV (TV and RR)? 
a. When NPPV is applied or removed, what are the MV volumes at 1, 5, and 15 
minutes of use and/or removal, and is the volume change significant? 
b. Is there a significant difference in the number of respiratory events (any recorded 
MV < pred40% value; any SpO2 recording <92% lasting ≥1 minute while on 
oxygen at 2-4 liters/minute, or any drop in SpO2 ≥4% from the preoperative SpO2 
recording lasting ≥1 minute when no supplemental oxygen is used) between 
participants who receive NPPV and those who do not during PACU recovery? 
 A prospective observational study was conducted to explore the relationship between 
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OSA severities in participants recovering from laparoscopic gastric bypass surgery (GBS) in the 
PACU to select postoperative outcomes.  Specifically, the relationships between TV, RR, & MV 
calculated from the ExSpironTM respiratory ventilation monitor (RVM), time to discharge from 
the PACU, and the effects of NPPV in the PACU were explored. 
 This study sought to identify relationships between OSA screened severity and recorded 
variables detecting hypoventilation in the PACU (pulse oximetry and minute ventilation data).  
The effects of NPPV therapy on minute ventilation were measured using an innovative 
respiratory volume monitor (RVM) as a method for identifying and improving ventilatory 
outcomes.  The study used a consecutive convenience sample of participants consented for RY 
or GS surgery.  
Population and Sample 
 In estimating sample size, one aspect of the study was determining the feasibility (Leon, 
Davis, & Kraemer, 2011) of the RVM instrument for measuring MV changes when CPAP was 
used.  Schumann et al. (2016) explored the relationship between OSA severity and postoperative 
respiratory depression (PORD) and postoperative apnea (POA) events.  Sample size for their 
study was 80 participants divided into mild (n =12), intermediate (n =25), and high (n = 43) OSA 
risk.  They found no “statistically significant differences” (p.  297) among groups regarding 
frequency of PORD and POA events.  Despite these findings, PORD and POA events occurred 
in all groups (8-40%).  Their study provides a basis for further inquiry.  What was not addressed 
was the correlation of arterial blood gases or SpO2 analyses when these respiratory events 
occurred.  In this research the sample participants were divided into mild vs. moderate/severe 
OSA groups to explore the relationships among the data. 
 Leon et al. (2019) noted that the nature of pilot studies should not be used to estimate 
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population effect size, instead a “clinically meaningful effect” (p. 5) should be sought.  In 
estimating pilot study sample size, Hertzog (2008) suggests a population sample of 40 to 50 for 
two groups is sufficient to perform independent τ-test with a probability of detection of 
differences 0.80, and an α = 0.05 between groups.  A minimum sample of 50 participants were 
sought for this study (n= 25 in each group).  It was estimated that six to eight laparoscopic 
gastric bypass cases were scheduled weekly at the data collection site. 
Inclusion criteria: Male and female English-speaking surgical candidates ≥18 years of age 
scheduled for general anesthesia for GBS (Gastric Sleeve (GS) or Roux en-Y (RY)) surgery, 
having a BMI of ≥35, answering “yes” to at least one STOP-Bang question (Appendix C), and 
willing to consent and participate. 
Exclusion criteria:  Participants who were not extubated after surgery, unable to give informed 
consent, and/or unwilling to be monitored with the ExSpironTM RVM machine.  
 Participant recruitment was continued until at least 25 participants’ data was collected in 
each OSA severity group (mild and moderate/severe with SBQ ≤3 or ≥4 respectively).  
Dichotomous classification for OSA severity was based on previous literature findings (Chudeau 
et al., 2016; Dimitrov & Macavei, 2016; & Nagappa et al., 2015) where there was a consistent 
higher sensitivity for OSA related complications with higher SBQ scores.  Schumann et al. 
(2016) used similar cut-off points for grouping OSA risk.  A SBQ cut off score of 3 to 
differentiate mild from moderate/severe OSA risk was used for group selection.   
 Participant selection was used to assist in controlling for confounding variables and 
improve homogeneity during data analyses.  All participants had surgery performed by the same 
surgical group in the same facility, and recovered from general anesthesia in the same PACU.  
The ExSpiron™ RVM was previously used in an orthopedic surgical population with patients 
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over 65 years of age undergoing total joint replacement to monitor for postoperative respiratory 
depression.  There were six RVM monitors available, which made it feasible to use the 
equipment, and required no modification for applying it to the research population.   
Participant Recruitment 
 Potential participants from a bariatric surgical clinic of two surgeons who performed their 
surgeries at the same large hospital in southeastern United States were recruited.  Participants 
underwent gastric bypass surgery from a single practice and were recruited for the study to 
reduce confounding variables, increase homogeneity of sampling, and provide a sample where 
results were used as a cause for further inference.  The nurse manager at the surgeons’ office was 
asked to give those scheduled for GBS a brochure describing the research study (Appendix E).  
The brochure included a brief explanation of the research purposes and to alert participants that 
the PI would meet and talk with them about the study on the morning of their scheduled surgery.  
Informed Consent   
 The PI met all potential participants in the preoperative area and fully explain the 
research study.  Participants were given a copy of the informed consent and HIPPA privacy 
authorization to read and sign (Appendix F) after inclusion criteria was confirmed.  Participants 
were given an opportunity to ask questions and then sign consent for the study including a 
HIPPA form for privacy per IRB policy.  Preoperative questions were asked using the SBQ and 
“OSA and Bariatric Preoperative Data Sheet” (Appendix G).  Participants received a duplicate 
signed consent and HIPPA form. Copies of participants’ consents and HIPPA forms were 
uploaded into their electronic record per IRB policy.  Paper documents and consents were filed 





 After obtaining consent, the PI completed the preoperative assessment and obtained 
physiological and demographic data on participants.  Additional baseline data and preoperative 
information was extracted from the EHR and placed into REDCap (Appendix G) on the day of 
surgery.  Preoperative information included preoperative medications, age, weight, height, and 
co-morbid conditions (e.g. cardiopulmonary issues, endocrine disorders, BMI, and OSA history), 
and diagnosis of OSA.  All participants were assigned an identification number at time of 
inclusion to match additional data collection sheets. 
 Perioperative data was collected after surgery from the EHR record and during the 
participant’s PACU recovery period.  Information collected (Appendix H) included: 
Perioperative times; post extubation support of the airway; intraoperative opioid(s) type(s) and 
doses administered; neuromuscular, opioid, and benzodiazepine antagonist medication type(s) 
used; and opioid(s) type(s), dosage(s), and times administered in the PACU.  Additional 
perioperative data collected at PACU discharge time included the time in minutes when the 
patient met PACU discharge criteria. 
 Postoperatively, the PI observed and recorded pulse oximetry and RVM data, and NPPV 
use times and settings on the “OSA and Bariatric Sx Postoperative Event & Vital Signs Log” 
(Appendix I).  This allowed the PI to measure changes in MV when NPPV was applied or 
removed, and record respiratory events and related MV and pulse oximetry output. 
 All collected data was stored in REDCap, an IRB approved storage site that performs 
encryption and de-identification of stored data.  A laptop was used to input data, capturing SpO2 
and RVM recordings as NPPV is used in the PACU.  Paper forms were printed and used as a 
back-up data collection method (Appendices G, H, & I) if there were issues with entering data 
electronically. Copies of consents were uploaded and stored be per IRB policy.  All paperwork 
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was stored in a locked box at the PI’s office when not being used.  After completion of the study, 
all paper versions of identifiable PHI was secured and stored in a locked cabinet until forms are 
able to be shredded/destroyed per IRB policy.  PHI is kept on file in REDCap for future 
questions or issues related to this study or for additional research.  A de-identified data set was 
extracted and used for data analyses and reporting of findings.   
Setting 
 Study location was the perioperative surgical department at large medical center in the 
eastern United States.  The study was conducted during participants’ preoperative admission, 
surgery, and PACU recovery periods.  Prior to study initiation, PACU RNs and nurse managers, 
and anesthesia providers received information on the study design and purpose.  A study 
summary sheet (Appendix J) was distributed to PACU staff and anesthetists.  
Study Procedure 
Preoperative Setting  
 On admission to the preoperative area, participants were interviewed, and informed 
consent was be obtained.  Each participant was assigned a number for matching data in the 
REDCap system.  The following information will be asked by the PI and collected at time of 
consent and entered into REDCap (Appendix G): 
1. Height, weight, BMI calculations. 
2. STOP-Bang Score. Participants were screened and categorized as low or 
moderate/severe OSA via the SBQ assessment score, 1-3, or ≥ 4 “yes” answers 
respectively.   
3. Diagnosis of sleep apnea and AHI scores. 
4. NPPV type and settings if used at home. 
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5. Physical and medication histories including co-morbidities (hypertension, diabetes, 
asthma, orthopnea, dyspnea on exertion, or chronic obstructive pulmonary disease). 
Intraoperative Setting  
 The anesthesia provider transported participants to the OR for their scheduled surgery 
and continued with standard anesthesia induction and intubation.  Surgical preparation of the 
participant and surgery proceeded in a standard manner.  Before extubation in the operating 
room, electrodes were be placed on the participant’s chest for calibration of the RVM.  The PI 
entered the participant’s height, weight, age, and gender into the RVM machine before 
calibration.  Electrodes were connected to the RVM machine and a calibration of the RVM to the 
ventilator occurred.  This configured the calibrated MV thresholds for postoperative monitoring. 
If there was an error in the calibration or unusual reading or error entering the data on the RVM, 
the machine was recalibrated to the ventilator.  The RVM continuously measured ventilation 
patterns and alarmed when minute ventilation fell below 40% of the participants predicted MV 
values (pred40%) calibrated to the participant’s gender, height, and weight (Schumann, et al., 
2016) calculated within the RVM software.   
PACU Setting  
 Upon entry to the PACU the participant was attached to the standard PACU monitors and 
anesthesia personnel completed their transfer report.  RNs performed their standard assessment 
and interventions for all patients in the PACU.  The PI verified that the pulse oximetry was on 
and that NIBP monitors were set at 5-minute intervals.  Typically, NIBP monitors are set at 15-
minute intervals.  Increasing the frequency helped correlate standard vital sign data (HR, blood 
pressure, pulse oximetry) to RVM data (RR, TV, MV).    
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 The times on the RVM were noted and matched to the PACU monitor for future data 
analyses.  During a previous pilot study conducted by the PI, retrospective analysis determined 
that the RVM internal clock times were up to 13% different from actual times.  This led to a 
decision to match the times on the RVM with PACU monitors.  The following data was obtained 
during PACU recovery and placed into the REDCap data storage system: 
1. Pulse oximetry, heart rate, and blood pressure recordings upon admission and at 5-minute 
intervals (admission, 5, 10, 15, 20…to 45 minutes) of PACU time, and when SpO2 is 
noted be ≤90%. 
2. RVM data (MV, TV, RR) recorded upon admission and at 5-minute intervals of PACU 
time, and when RVM notes MV < pred40% of their calculated baseline MV. 
3. Oxygen flow rates and devices used for delivery. 
4. Times of NPPV application, discontinuation, and oxygen flow rates if Boussignac CPAP 
is used, or pressure settings of other NPPV devices. 
5. Respiratory parameters (TV, RR, SpO2, and MV values) with NPPV application after 1, 
5, and 15 minutes of use and after 1, 5, and 15 minutes of discontinuing NPPV therapy. 
 Upon completion of PACU recovery, RVM electrodes were removed from participants’ 
chest. Sites were observed for redness or rash and monitor were cleaned. Participants were 
transferred to their designated stepdown unit at the discretion of PACU nurse.   
Data Collection After PACU Discharge  
 Participant’s data recorded in the RVM was extracted using a designated thumb drive.  
This assisted in post-hoc comparison of PORD and POA frequencies between OSA risk and 
NPPV therapy groups.  Vital sign spreadsheets were reviewed to identify any missing variables 
for analyses.  The PI obtained the time patients were ready for PACU discharge.  PACU nurses 
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determined readiness for discharge by using the Modified Aldrete scoring instrument (Appendix 
D).  The five-item instrument has each criterion rated on a 0-2 scale, assessing activity, 
respiration, circulation, consciousness, and oxygen saturation.  A minimum aggregate score of 
9/10 was required to meet postoperative discharge criteria (Mayers, Haas, & Convery, 2012).  
The times were matched to the RVM output for analysis of the number of hypoventilation and 
apnea events during PACU recovery.  MV data was extracted and uploaded into REDCap.  The 
following data was be collected after PACU recovery: 
1. Time in minutes from PACU admission to completing discharge criteria. 
2. Continuous RVM data output including TV, RR, and MV values for post-hoc analyses 
comparing ventilatory output to OSA severity, and NPPV application/no application 
groups.   
3. Perioperative narcotic types, dosages and PACU administration times, intraoperative 
reversal agents, NPPV use times, and duration of anesthesia (Appendices H, I).  
Instruments 
 Perioperative instruments used included the Modified Aldrete scoring instrument, the 
RVM monitors with associated disposable electrodes, the SBQ, standard vital sign monitors, and 
nursing PACU flow sheets recorded in the patient’s EHR.  The RVM recorded tidal volumes and 
respiratory rates, calculating MV rates continuously in real-time.  The RVM recorded and stored 
participant’s data within the monitor’s software and was extracted, matched, and coded with the 
EHR data in REDCap.  Participant’s EHR data and RVM output was uploaded into REDCap for 
storage, de-identification, and analyses.  Original paper data was available for use as a backup in 
case the REDCap site was offline.  The paper consents and thumb drive with RVM data was 
secured in a locked cabinet in a secure office (3110) at the ECU College of Nursing. 
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Data Analysis and Statistics 
Statistical analyses was completed utilizing the Statistical Package for the Social 
Sciences (SPSS), version 24.  An initial analysis of all data points were reviewed and coded for 
appropriate statistical use.  The sample size of at least 50 patients (25 per group) was used to 
approximate clinically significant differences between group outcomes. 
Research Question 1:  Is there a difference in pulse oximetry recordings, respiratory rates, 
minute ventilation (MV) patterns, and PACU length of stay between OSA severity groups (mild 
vs. moderate/severe), OSA history groups (previously diagnosed vs. no formal diagnosis), or 
NPPV use groups (NPPV vs. non-NPPV) as measured by the STOP-Bang and preoperative 
evaluation questionnaires? 
 Descriptive statistics for demographic and anthropometric measures (means, percentages, 






Research	Question	2:		What is the association of pulse oximetry recordings to respiratory 
parameters (TV, RR, MV) measured by the RVM?  
a. Which monitor identifies changes in respiratory parameters earlier (SpO2 
recording 90-92% (moderate hypoxemia) lasting ≥1 minute while on oxygen at 2-
4 liters/minute or a drop in a SpO2 recording ≥4% from baseline lasting ≥1 
minute when no supplemental oxygen is used vs. RVM recording of a MV < 
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pred40% (moderate hypoventilation)), and is the detection time difference 
significant? 
b. When the RVM detects hypoventilation (MV < pred40%) or apnea events (no 
detected RR >10 seconds), are there associated changes in pulse oximetry (SpO2 
< 92% when on oxygen 2-4 liters/min or drop in SpO2 ≥4% from the preoperative 






Research Question 3:  How does NPPV application affect MV (TV and RR)? 
a. When NPPV is applied or removed, what are the MV volumes at 1, 5, and 15 
minutes of use and/or removal, and is the volume change significant? 
b. Is there a significant difference in the number of respiratory events (any recorded 
MV < pred40% value; any SpO2 recording <92% lasting ≥1 minute while on 
oxygen at 2-4 liters/minute, or any drop in SpO2 ≥4% from the preoperative SpO2 
recording lasting ≥1 minute when no supplemental oxygen is used) between 










Study Limitations and Potential Difficulties 
 Limitations to the study regarding sampling included having participants undergo gastric 
bypass procedures at a single facility, with a diagnosis of or a suspected OSA history.  The 
sample may have not been representative and generalizable to other surgical patient populations 
with OSA.  However, homogeneity was sought to limit confounding variables, to determine if 
significant ventilation differences and outcomes exist between groups, and explore the feasibility 
of the RVM for postoperative monitoring and future prospective research. 
 Other potential limitations included delays in participant recruitment with variable 
surgical case volumes.  The PI minimized this by regularly reviewing the operating room’s daily 
schedule, providing brochures in the surgeons’ office, and contacting participants in the 
preoperative surgical unit after they were seen by the preoperative RN.  Measurement and data 
collection issues may have related to removal of electrodes as well as potential monitor failures 
and calibration issues.  The PI ensured vital sign monitors were in place and recording upon 
PACU entry, and electrodes were replaced as needed in the event of dislocation/breakage.  RVM 
monitors were plugged into wall outlets to reduce the likelihood of power failure.  This allowed 
the RVM to continually record ventilatory data throughout the PACU stay allowing the 
researcher to correlate this information to participants’ pulse oximetry. The PI remained at the 
bedside collecting data and monitoring the patient’s progression throughout the PACU stay to 
ensure accuracy of data collection.  
	
	
CHAPTER 4: RESULTS 
	
 A prospective observational study was performed at a major medical center in the 
Southeastern United States.  The purpose was to examine the effects of obstructive sleep apnea 
(OSA) severity on ventilation changes and the results of non-invasive positive pressure 
ventilation use in the Postoperative Anesthesia Care Unit (PACU).  
 From June 29th, 2018 through October 30th, 2018 a consecutive convenience sample of 
prospective surgical participants undergoing gastric bypass (gastric sleeve, Roux en-Y 
anastomosis) surgery were interviewed.  A total of 68 participants were contacted to participate 
immediately prior to surgery in the preoperative area.  Of these, 67 agreed to participate.  The 
data from 17 participants were excluded for the following reasons: monitor/calibration issues (n 
= 8) primarily from not having time to adequately establish a baseline minute ventilation value; 
excessive patient movement/monitoring issues observed (n = 5); unavailability of the researcher 
during the entire data collection process (n = 3); and one participant’s ventilation data not 
recorded in the respiratory volume monitor (RVM).  The final sample included 50 participants 
with 25 in each assigned OSA risk group.  
Sample Description 
 Forty-four participants (88%) underwent gastric sleeve surgery compared to six for Roux 
en-Y anastomosis.  They included a majority of females 39 (78%), White/Caucasian (61%) with 
an average age of 47 years and a BMI 44.2 (37.9-58.1).  Sixty-four percent had a neck 
circumference greater than 40cm (see Table 1). 
 Sixteen (32%) subjects reported a physician diagnosis of OSA.  Of these 16 subjects, 15 
had received a non-invasive positive pressure ventilation (NPPV) mask.  Twelve stated they 
were compliant at home with wearing their mask greater than four hours per night.  Home 
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pressure setting ranged from 5cm H20 to 17cm H2O with a mean pressure of 11.6 cm H2O.  
Participants had a variety of chronic health conditions including hypertension (52%), diabetes 
(32%), asthma (36%), with 24% reporting dyspnea with activities.   
Individual STOP-Bang Questionnaires with eight item “yes or no” (SBQ) responses were 
consistent with other health-risk findings in addition to having an inclusion criteria of a BMI 
>35kg/m2.  The most common measured risk factor was large neck circumference (64%), and the 
most common self-report responses were diagnosis of hypertension and someone reported them 
snoring (50%), and age greater than 50 years (42%).  The least noted SBQ response was report 
that someone observed the participant stopping breathing (2%).  Participants’ collective mean 
SBQ score was 3.7, and ranged from 1-7.  Each participant was assigned OSA group based on 
his or her aggregate SBQ score.  Those with a score ≤ 3 designated as “mild OSA risk” and 





Demographic Characteristics of Participants (n = 50) 
           Characteristic n % 
Age at time of study (years)   
   23-40         15 30 
   41-50         14 28 
   51-60         18 36 
   61-71           3   6 
Gender   
   Female         39 78 
   Male         11 22 
Race   
   Black/African American         18 36 
   White/Caucasian         32 64 
Surgery Type   
   Gastric Sleeve Resection         44 88 
   Roux en-Y Anastomosis           6 12 
OSA Risk Group   
   Mild         25 50 

































Physiological Measurements (n = 50) 
           Measurement M SD 
Height (cm) 165.83                                    0.09 
Weight (kg) 121.71          17.34 
BSA 2.25            0.20 
BMI 44.21            5.11 
Neck Circumference (cm) 43.32            4.96 
STOP-BANG total Score  3.70            1.68 
Preoperative Laboratory Values  
   Serum Sodium Bicarbonate (mg/dl) 25.26                                    2.63 
   Preoperative Serum Hemoglobin (mg/dl) 13.24            1.08 
Ventilation Parameters  
   Predicted Minute Ventilation 8.12            1.10 
   40% Predicted Minute Ventilation Calculated 3.23            0.44 
   Home Mask Pressure Setting (cm H2O)         11.6                        3.35 
 
Analyses Related to Research Questions 
Research Question 1 
Is there a difference in pulse oximetry recordings, respiratory rates, minute ventilation (MV) 
patterns, and PACU length of stay between OSA severity groups (mild vs. moderate/severe), 
OSA history groups (previously diagnosed vs. no formal diagnosis), or NPPV use groups 
(NPPV vs. non-NPPV) as measured by the STOP-Bang and preoperative evaluation 
questionnaires? 
Research Question 1 Analyses 
 There were 25 subjects in the mild and 25 subjects in the moderate/severe group.  OSA 
severity group (mild vs. moderate/severe) clinical measures and postoperative outcomes were 
compared for differences (Table 4) using independent samples t-tests.  Participants in the 
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moderate/severe OSA group were significantly older and had larger neck circumferences.  The 
magnitudes of these differences were large respective to their effect sizes (eta squared = 0.26 & 
0.29).  Statistical differences in mean PACU length of stay were noted between mild and 
moderate/severe OSA groups with longer PACU recovery times in the mild group (p = .04).  The 
magnitude this difference was moderate (eta squared = .086).  The mild OSA group received 
significantly more postoperative pain medication measured as mean morphine equivalents than 
those with moderate/severe OSA risk with a moderate effect size (eta squared = 0.083) (see 
Table 4).    
 
Table 4 
Perioperative Measurements Between OSA Assigned Groups 
      Mild  
(n = 25) 
Moderate/Severe  
(n = 25) 
  
     Outcome M SD M SD   t p eta2 
Age  41.32   9.05  52.76 10.37 -4.16 <.001  .26 
BMI   44.97   5.36  43.45   4.84   1.05 .30 .022 
Neck Circumference  40.68   3.14  45.97   5.08 -4.43 <.001  .29 
Surgery Duration  41.80   9.98  43.84 13.42   -.61 .55  .019 
Surgical Morphine   
equivalents.  
 14.93   6.28  12.29   5.56  1.58 .12  .049 
PACU Length (min)  78.12 25.86  63.84 21.56  2.12 .04  .086 
PACU Morphine 
Equivalents 
   8.14   5.72  12.13   7.68 -2.09 .04  .083 
Admission SpO2  96.0   3.55  96.7   2.97   -.74 .47  .011 
 
 Postoperative ventilatory outcomes were continually monitored with pulse oximetry and 
respiratory rate recorded at five-minute intervals and continuous ventilation data (tidal volumes, 
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respiratory rates and calculated minute ventilations) retrieved from the ExSpironTM (RVM) 
machines.  The mean postoperative outcomes were obtained for the first 45 minutes of recovery.  
Apnea events, and the percentage of time participants had low minute ventilation readings were 
counted from the continuous RVM data.  No significant differences were found between OSA 
severity groups (see Table 5). 
Table 5 
Postoperative Ventilatory Outcomes Between OSA Assigned Groups 
      Mild  




     Outcome M SD M SD   t p eta2 
Pulse Oximetry  96.7   2.50  96.8   2.13     -.141 .89 .000 
Respiratory Rates  17.04   4.71  15.94   2.98      .986 .33 .020 
Minute Ventilation    5.56   2.16    5.95   1.66     -.706 .48 .010 
RVM Minute 
Ventilation Output* 
   5.96   2.62    6.42   2.25   -.67 .50 .009 
Desaturation Events      .48   1.05      .64   1.08     -.533 .60 .006 
Low MV Events    2.80   3.18    3.64   4.17     -.801 .43 .013 
Apnea Events      .68   3.40      .20     .58      .696 .49 .010 
Percent Low MV 
first 45 minutes 
 18.85 28.91  12.26 12.97    1.039 .31 .022 
*ExSpironTM RVM 1-Minute Data Recordings Averaged 
 To further explore the first research question the series of independent-samples t-tests 
were repeated between formal OSA diagnosis groups (Table 6), and home NPPV mask wearers 
(Table 7).  The purpose was to determine if there was a difference in pulse oximetry recordings, 
respiratory rates, minute ventilation (MV) patterns, and PACU length of stay between groups.  
There were no statistical differences in outcomes between those formally or not pre-diagnosed 
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with OSA.  Sixteen participants with a previous OSA diagnosis, 15 were given home NPPV 
masks (continuous or automated positive airway pressure masks), but three were non-compliant 
in wearing the mask on a regular basis (>4hrs average use/night) (Table 7).  No ventilatory 
differences or PACU length of stay were found between NPPV mask user/non-user groups.  
Table 6 
Postoperative Outcomes Between Formal OSA Diagnosis Groups 
      No OSA Hx 
(n = 34) 
Positive OSA Hx  
(n = 16) 
  
     Outcome M SD M SD   t p eta2 
Pulse Oximetry  96.9   2.55  96.35    1.66   .82 .42 .014 
Respiratory Rates  16.49   4.00  16.49    3.94     .005 .99 .000 
Minute Ventilation    5.65   1.95    5.98    1.89     -.573 .57 .007 
RVM Minute 
Ventilation Output* 
   6.06   2.39    6.48    2.57     -.566 .57 .007 
PACU Length (min)  69.15 26.53  74.88  20.28     -.763 .45 .012 
*ExSpironTM RVM 1-Minute Data Recordings Averaged 
 
Table 7 
Postoperative Outcomes Between Non-NPPV Users and NPPV-Complaint Users 
      No NPPV Use 
(n = 38) 
NPPV Use >4hrs 
(n = 12) 
  
     Outcome M SD M SD   t p eta2 
Pulse Oximetry   96.8   2.44  96.5   1.85     .336 .74 .002 
Respiratory Rates   16.49   4.07  16.48   3.67     .009 .99 .000 
Minute Ventilation     5.69   1.96    5.96   1.85    -.423 .67 .004 
RVM Minute 
Ventilation Output* 
    6.1   2.32    6.6   2.80    -.671    .51 .009 
PACU Length (min)   70.6 25.76  72.1 21.72    -.176 .86 .000 
*ExSpironTM RVM 1-Minute Data Recordings Averaged 
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Research Question 2 
What is the association of pulse oximetry recordings to respiratory parameters (TV, RR, MV) 
measured by the RVM?  
a. Which monitor identifies changes in respiratory parameters earlier (SpO2 
recording 90-92% (moderate hypoxemia) lasting ≥1 minute while on oxygen at 2-
4 liters/minute or a drop in a SpO2 recording ≥4% from baseline lasting ≥1 minute 
when no supplemental oxygen is used vs. RVM recording of a MV < pred40% 
(moderate hypoventilation), and is the detection time difference significant? 
b. When the RVM detects hypoventilation (MV < pred40%) or apnea events (no 
detected RR >10 seconds), are there associated changes in pulse oximetry (SpO2 
< 92% when on oxygen 2-4 liters/min or drop in SpO2 ≥4% from the preoperative 
SpO2 lasting ≥1 minute when no supplemental oxygen is used)? 
Research Question 2 Analyses 
 Participants were monitored for low minute ventilation events (MV < pred40%) and mild 
and moderate hypoxemia as measured by pulse oximetry.  A total of 178 respiratory events 
occurred.  Of these respiratory events, 166 were low minute ventilation.  There were a total of 28 
mild or moderate hypoxemic events. Of these, 16 occurred when low minute ventilation was also 
detected and 12 occurred when there was a normal minute ventilation. 
 The 12 hypoxemia events when normal minute ventilation occurred were explored in 
more detail.  Of these eight events, five participants were not receiving supplemental oxygen. 
Three participants had previous intermittent low MV periods of less than one-minute duration 
thus not causing the RVM to alarm.  Others were moving in bed or at the bedside (n = 1) or 
received intravenous opioids or sedatives (n = 2).  One of the eight participants was using their 
home CPAP without supplemental oxygen.   Chronic health conditions of the eight participants 
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using oxygen included hypertension (n = 3), asthma (n = 3), and dyspnea on exertion (n = 2), 
with four reporting using CPAP at home.  Of the four participants receiving supplemental 
oxygen, they had either previous low MV events or received opioids, reducing their MV but not 
less than the MVpred40%.  Of all total 28 hypoxemia events very few were noted to be one 
minute or longer in duration and did not meet the study’s definition of moderate hypoxemia.   
 The 178 low MV incidents were investigated to determine the effects of NPPV and 
supplemental oxygen therapies on event duration.  Independent samples t-tests explored the 
differences in mean duration of hypoventilation events.  Overall, oxygen therapy did not change 
the duration of the hypoventilation event, however NPPV mask application reduced mean 
duration time by nearly one minute (see Table 8).  Only four subjects experienced apnea events 
(AE).  All but one AE had a correlating SpO2 value ≥94%. One participant had 17 AE, but had 
no desaturation events.  The other participants (n =3) received an opioid prior to all but one of 
their apnea events. 
Table 8 
Effect of NPPV on Duration of Low MV Events’ Duration  
      No NPPV  
(n = 139) 
NPPV  
(n = 39) 
   
 M SD M SD df t p eta2 
Event Duration in 
Minutes 
2.89 4.51 1.92 1.79 176  2.02 .045 .023 
 
Research Question 3 
 How does NPPV application affect MV (TV and RR)? 
a. When NPPV is applied or removed, what are the MV volumes at 1, 5, and 15 
minutes of use and/or removal, and is the volume change significant? 
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b. Is there a significant difference in the number of respiratory events (any recorded 
MV < pred40% value; any SpO2 recording <92% lasting ≥1 minute while on 
oxygen at 2-4 liters/minute, or any drop in SpO2 ≥4% from the preoperative SpO2 
recording lasting ≥1 minute when no supplemental oxygen is used) between 
participants who receive NPPV and those who do not during PACU recovery?	
Research Question 3 Analyses 
 Fifteen participants received postoperative non-invasive positive pressure (NPPV) 
support.  Data was analyzed for 13 participants.  Two subjects were excluded because one 
received Boussignac CPAP (BCPAP) less than 15 minutes and the other’s home CPAP was not 
discontinued in the PACU.  Of the 13 participants, their average age was 55 years, with a BMI 
mean of 42.5.  Eight received a BCPAP and eight were females with a mean duration of NPPV 
use of 34.9 minutes.  Of the BCPAP users, 75% of the masks were applied when the participant 
was in the operating room prior to transport to PACU.  Overall mean start time of NPPV therapy 
was 12 minutes after PACU admission. 
 Multiple paired-samples t-tests were conducted to compare baseline respiratory rates, 
minute ventilation mean scores, and TV and MV percent changes from baseline during and after 
NPPV use (Tables 9 & 10).  Baseline measurements were obtained from values recorded at the 
time of NPPV application with designated paired-samples t-tests at measured intervals (1, 5, and 
15 minutes after application, at removal, and 1, 5, and 15 minutes after removal).  Predicted MV 
100% values were used as a physiological measurement based on predicted BSA and gender.  
Percent change from baseline and	percent	of	the	predicted	MV	100%	were	measured.		Tidal 
volume measurements were compared against a percentage change from baseline and a 
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percentage of their predicted TV (based on predicted body weight*5ml/kg).   Mean changes from 
baseline MV values were used to compare repeated measures during application and removal.   
 When NPPV was applied, percent of predicted TV and MV improved with highest 
percent change at time of mask removal.  There was a significant difference between mean 
baseline percent of predicted MV scores and percent of predicted MV at time of NPPV removal 
(see Table 9).  Following NPPV removal percent scores decreased.  Similarly, mean TV 
measurements improved between baseline and at the time of discontinuation and TV decreased 
after NPPV removal.  A paired-samples t-test of MV percent change from baseline to NPPV 
removal was statistically significant (see Table 10).  A paired-samples t-test was performed 
between TV predicted mean values when NPPV was off for 1-minute and the NPPV was off for 
5-minutes.  Participants’ predicted tidal volume percentage mean scores were reduced 25%, 
which was clinically and statistically significant (p = .027, 2-tailed).  A paired-samples t-test was 
performed substantiate the decline in TV in milliliters (ml) change and found it to be reduced 
from a mean of 473ml to 354ml (p = .029, two-tailed).  No other repeated measures were found 




Paired-samples t-tests of Ventilation Measures With Application and Removal of NPPV Against 
Values at Baseline NPPV Application 
 Ventilation Measures (n = 13) 
                     
Respiratory Rates 
 Percent of Predicted 
TV  
Percent of Predicted 
MV 100% 
Time Event M SD  M SD M SD 
Baseline  16.47 5.12  124.8 59.13 70.36 36.69 
NPPV on 1 Min 15.09 2.79  134.9 60.70 71.92 36.38 
NPPV on 5 Min 16.22 4.55  132.8 58.95 74.12 35.46 
NPPV on 15 Min 16.43 5.25  125.1 62.84 69.96 36.75 
NPPV Removal 16.89 3.81  154.9 70.49   91.50* 35.88 
NPPV Off 1 Min 14.66 3.18  159.6 72.86 81.39 33.27 
NPPV Off 5 Min 18.08 4.31  119.0 68.88 72.17 39.63 
NPPV Off 15 Min 16.89 4.17  137.3 65.37 78.36 33.52 
* significantly different from baseline measure p<.05 (2-tailed). 
Table 10 
Paired-samples t-tests of Percent Change in MV from Baseline MV Value  
Minute Ventilation Measure (n = 13) 
Time Event M SD t p  
Baseline 5.84 3.46   
NPPV on 1 Minute 5.95 3.33 -.167 .87 
NPPV on 5 Minutes 6.04 2.81 -.391 .70 
NPPV on 15 Minutes 5.65 2.79  .292 .78 
NPPV Removal   7.45* 3.17   -2.14 .05 
NPPV Off 1 Minute 6.56 2.53 -.997 .34 
NPPV Off 5 Minutes 5.89 3.31 -.052 .96 
NPPV Off 15 Minutes 6.29 2.61 -.617 .55 




 Postoperative outcomes were compared to determine a difference in postoperative 
respiratory events between participants who received postoperative NPPV therapy and those that 
did not (n = 35).  Independent-samples t-tests were first conducted to determine differences in 
perioperative measurements, opioid doses, and duration of their surgical procedures (Table 15).  
Participants who received postoperative NPPV were statistically older (M = 54.73) than those 
who did not (M = 43.74) with a large effect size (eta squared = .205).  They also had larger neck 
circumferences (p = .015) with a moderate to large effect size (eta squared = .117).  There were 
no other statistical differences in means analyzed, including height, weight, and perioperative 
opioid morphine equivalents. 
Table 11 
Perioperative Measurements Between Post-Extubation NPPV Application and Non-
Application Groups 
      No Application  
(n = 35) 
NPPV Use  
(n = 15) 
  
     Outcome M SD M SD t p eta2 
Age 43.74 10.06 54.73 10.26  -3.519   .001 .205 
BMI  44.79   5.52 42.84   3.81   1.245 .22 .031 
Neck Circumference 42.23   4.55 45.89   5.08  -2.516   .015 .117 
Surgery Type   1.11     .32   1.13     .35    -.186 .85 .001 
Surgery Duration 40.51   8.22 48.20 16.58   -1.708 .11 .057 
Surgical Morphine   
equivalents.  
13.59   5.55 13.67   7.22    -.043 .97 .000 
PACU Length (min) 70.32 24.66 72.53 25.41    -.289 .77 .002 
PACU Morphine 
Equivalents 
10.17   6.44 10.04   8.41     .057 .16 .000 
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 Finally, independent-samples t-tests were conducted resulting in no significant 
differences in low MV or desaturation events, mean apnea events, or mean lengths of PACU stay 
(Table 16).  Of the participants that received NPPV, not all were diagnosed with OSA (n = 10) or 
were in the moderate/severe OSA group (n = 12).  Some received the Boussignac NPPV mask 
after extubation (n = 6) in the operating room.  NPPV application was at the discretion of the 
nurse anesthetist or PACU nurse with most participants not receiving NPPV (home mask or 
BCPAP) until after a period of recovery time in the PACU.  Application times ranges from 5 
minutes before PACU arrival to 65 minutes after admission (M = 12.3 minutes).  Mean 
respiratory events, particularly low MV events were more frequent with postoperative NPPV and 
were approaching significance.  However, mean lengths of low MV events were significantly 
shorter when NPPV was used (Table 12).  Postoperative NPPV use participants were statistically 
older and had larger necks, suggesting the therapy improved their ventilatory outcomes. 
Table 12 
Postoperative Respiratory Outcomes Between Post-Extubation NPPV Application and Non-
Application Groups 
 No Application  NIPPV Use    
      (n = 35) (n = 15)   
     Outcome M SD M SD t p eta2 
Pulse Oximetry  96.6 2.40 97.1 2.06 -.753 .46 .011 
Total Respiratory 
Events 
2.94 3.14    4.93 4.42 -1.81 .08 .064 
     Low MV Events 2.63   3.097    4.60 4.64 -1.77 .08 .061 
     Desaturations   .51   1.011      .67 1.18 -.465 .64 .004 
Apnea Events    .03    .169    1.40 4.37 -1.215 .25 .029 




CHAPTER 5: DISCUSSION 
	
Introduction 
 In this prospective observational research dissertation the effects of obstructive sleep 
apnea (OSA) severity risk on postoperative ventilatory patterns was documented.  The 
performance of an impedance device that identifies ventilatory events and respiratory depression 
was compared to “standard” monitors used in a PACU setting; and the effects of postoperative 
non-invasive positive pressure ventilation (NPPV) therapy examined.  By using a non-invasive 
respiratory volume monitor (RVM) to directly measure respiratory rates (RR) and tidal volumes 
(TV), participant’s minute ventilation (MV) was continuously calculated and displayed for 
analyses.  Fifty participants assigned to one of two OSA risk groups were observed in the PACU 
setting after receiving general anesthesia to explore the research questions introduced in Chapter 
One.  A discussion of the findings, as well as study assumptions, study strengths and limitations, 
with related future implications for practice and research will be discussed.  
Summary of Findings 
Finding One 
 In this dissertation study no statistical difference was found in respiratory events between 
OSA severity (mild vs. moderate/severe), diagnosis of OSA (previously vs. no formal diagnosis), 
or NPPV use (NPPV vs. non-NPPV).  Moderate/severe OSA (S-OSA) participants were 
statistically older and had larger neck circumferences than the mild-risk OSA (M-OSA) group 
participants.  An anecdotal finding was the M-OSA group received less postoperative opioid 
morphine equivalents, and had a longer mean PACU stay compared to the S-OSA group.  This 
may suggest there are underlying physiological factors not accounted/screened for in this study.  
Variations in pain management strategies and opioid administration techniques were not 
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considered.  Regardless of other factors, the results of STOP-Bang Questionnaire (SBQ) and 
subsequent assignment of groups by the researcher did not correlate with any differences in 
postoperative ventilation events or outcomes between OSA-assigned groups. 
 This finding may be of importance clinically as practitioners are faced with choosing 
preoperative screening questionnaires or questions to help identify potential and real issues 
during perioperative periods.  The SBQ has been used on a variety of patent populations (Nunes 
et al., 2016; Bamgbade et al., 2016; Proczko et al., 2014; Schumann et al., 2016) and tested 
against polysomnography (Chung, Yang, & Liao, 2013; Nagappa et al., 2015).  Nevertheless, 
limitations exist with respect to its’ ability to predict perioperative OSA-related events as seen in 
this study.  The SBQ was originally designed for risk-stratification for presence of OSA, not for 
the purpose of identifying patients “at risk” for postoperative respiratory depression.  So, not 
surprisingly, this study did not find a correlation between positive STOP-Bang severity and 
episodes of postoperative respiratory depression. 
 Many factors could affect the likelihood of patients experiencing a respiratory event.  
Some of these include administration of perioperative opioids incomplete/partial reversal of 
neuromuscular blockade, severity of OSA, duration of surgery, and facial or airway edema.  
Other physiological differences not measured (e.g. genetics and/or sensitivity to opioids and 
other medications) may also affect changes in perioperative ventilatory patterns (Lam et al., 
2016; Subramani et al., 2017). 
 In this study the SBQ was used to categorize participants into two risk groups.  Of the 
eight item responses the questions with the highest frequency of “yes” responses were BMI 
>35kg/m2, positive history of snoring, age >50 years, neck circumference >40cm, and subjective 
response of daytime tiredness.  Other questionnaires may be more objective and useful in 
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categorizing OSA risk (Deflandre et al., 2017).  The SBQ is used to assign OSA risk into one of 
three groups (low, intermediate, or high).  However, Chung et al. (2013, p. 2056) determined that 
individuals with a SBQ score of ≥4, as having a “high sensitivity” for severe OSA.  For this 
study, participants were grouped into M-OSA and S-OSA risk groups with respective SBQ totals 
≤3 or ≥4. 
 Schumann and colleagues (2016) similarly reported no differences between assigned 
OSA risk groups and postoperative respiratory depression or apnea events.  However, 
Fernandez-Bustamante et al. (2017) reported that participants screened positive for OSA but 
without a formal diagnosis of OSA had similar postoperative respiratory events, but longer 
length of admission and required more respiratory interventions than those presenting with a 
formal OSA diagnosis.  These finding were similar with Xara and colleagues (2015) who found 
that a SBQ > 3 (reported as “high risk”) had more adverse respiratory events, and hypoxia 
incidents than the low risk group (SBQ < 3).  In this study, the PI included only obese 
participants undergoing bariatric surgery.  This may have influenced the postoperative outcomes, 
as BMIs were similar between sub-groups.  Results may not be reflective of other populations 
receiving different surgical procedures.  M-OSA and S-OSA participant assignments for this 
study helped support the importance of screening for but not relying upon a questionnaire’s 
results to predict postoperative outcomes.  More research is needed into applying the SBQ to 
different surgical populations. 
 Study outcomes were similar to Schumann and colleagues (2016), where no group 
differences in postoperative respiratory depression or apnea events were seen between assigned 
groups.  Therefore, larger sample sizes and diverse surgical populations may demonstrate 
differences in respiratory outcomes.  A “universal approach” to monitor for and manage apnea 
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and respiratory depression may be more realistic for any patient screened or perceived to be “at 
risk” for sleep apnea.  Considering each patient as having an equal potential for airway 
complications may be more prudent.  Instead of focusing on the assignment of “potential risk” 
preoperatively, more robust methods for monitoring and assessing for ventilatory changes may 
be more practical. 
Finding Two 
 The RVM outperformed traditional pulse oximetry monitoring to alert the researcher 
when the patient experienced a reduction in their minute ventilation, particularly after parenteral 
opioid administrations.  There was a negative correlation to RVM notification of hypoventilation 
and reductions in pulse oximetry.  This finding may suggest a change is needed in how 
practitioners monitor for and identify real or potential ventilatory depression.  Only 12 
desaturation events (6.7%) were noted without an accompanying decrease in minute ventilation.  
Most of the desaturation events were less than one minute in duration, as the nurse was alerted 
by the alarm or the saturation increased above the alarm threshold.  Many desaturation events 
were preceded by previous decreases in MV at or below the pred40% threshold, or were noted 
when the participant was observed moving in bed.  The utility of the RVM to identify 
hypoventilatory states was similar to previous research measuring ventilatory patterns during 
moderate sedation procedures (Ebert et al., 2015) and effects of opioid administration on 
postoperative ventilatory patterns (Voscopoulos et al., 2014) 
 RVM results support previous findings in the literature: Ventilation and oxygenation are 
related but not the same, especially when supplemental oxygen is used (Sivilotti et al., 2010).  
Supplemental oxygen therapy may mask apnea and hypoventilation events (Gross et al., 2014), 
increasing circulating CO2 (Mehta et al., 2013).  In examining ventilatory patterns when oxygen 
81	
	
therapy was off, pulse oximetry was five-times more likely to display a desaturation event than 
when supplemental oxygen was in use.  This finding suggests the possible benefits of weaning 
off oxygen therapy as soon as it is safe and reasonable so changes in pulse oximetry can more 
closely correlate with potential or real hypoventilation events.  In this study, the RVM was 
superior in detecting compromised ventilation prior to hypoxemic events.  Most participants 
were receiving supplemental oxygen, which supports previous finding and provides a basis for 
further inquiry into the ability of the RVM to be used in other patient populations to monitor for 
changes in ventilatory patterns instead of observing changes on pulse oximetry alone. 
Finding Three 
 The NPPV masks used in this study were the participants home CPAP (n = 6) and the 
Boussignac CPAP (BCPAP) (n = 9) with one participant’s data in each group not used for 
analyses.  The BCPAP was often applied earlier than home-NPPV devices.  Application times 
were at the discretion of the anesthesia provider or RN, and usually occurred before transport to 
or upon arrival in the PACU.  
 Somewhat surprisingly, low MV events were more frequent with patients who had 
postoperative NPPV therapy initiated.  However, there is no way to determine the frequency of 
low MW events these patients might have had, if preventative NPPV had not been established, 
but it likely would have been a larger number.  Overall, NPPV therapy was applied to 
participants who were older and had larger necks.  Both of these factors have been associated 
with depressed postoperative ventilatory patterns, suggesting their baseline risk for obstructive 
events may have been elevated.  Having objective data that identifies those patients who are 
experiencing postoperative decrements in MV would inform patient care decisions in real time.  
When participants were receiving NPPV the duration of the respiratory depression event was 
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statistically shorter in duration.  The application of NPPV may have reduced more severe effects 
of post-operative obstructive ventilation breathing patterns.  
 These findings support previous literature on the mechanism of NPPV to improve 
ventilation.  As the airways are opened and supported with positive pressure, respiratory function 
can be preserved (Nigelin et al., 2009), reducing AHI severity over time (Laio et al., 2013), and 
increase participants’ level of alertness, reducing REM sleep percentages.  This results in a more 
awake and better ventilating patient in the PACU, potentially reducing airway events and length 
of stay.  Brousseau et al. (2014) suggested proactive postoperative use of CPAP is an area where 
improvement could be made to reduce length of stay and improve respiratory function.  BiPAP 
was not used in this study and is a limitation of the findings.  The clinical application of the 
device needs further research as it both opens the closed glottis structures and provides positive 
support to increase tidal volumes. 
 The RVM was able to provide digital output on changes to ventilatory parameters (RR, 
TV, and MV) and the effects of the NPPV mask before application, during use, and after 
removal.  Timed interval measurements of vital signs and ventilatory parameters were obtained 
when the participant was quietly breathing, not talking, or being stimulated.  Overall, no 
statistically significant changes in mean MV values or percentage change from baseline occurred 
except at the time of NPPV removal vs. baseline status.  CPAP and BCPAP physiologically 
provide constant pressure support to open airways and maintain patency, thereby maintaining TV 
but they do not provide positive pressure support during inspiration.  So, BiPAP application 





 A 25% reduction in mean TV was noted after NPPV mask removal for participants (n = 
13) who received NPPV therapy for at least 15 minutes and had their mask discontinued in the 
PACU.  This difference was measured comparing ventilation parameters at one and five-minute 
post-NPPV removal.  This suggests NPPV application maintains TV and thereby MV values 
when in use.  Participants in this study had a reduction in mean volumes >115 ml.  This only 
affected MV by 11% as respiratory rates likely attenuated the drop in TV by increasing 23% 
(mean increase in RR 15 to 18), maintaining MV.  This has potential clinical implications.  First, 
low MV may not be detected by RR monitors commonly used in PACUs since increased RR 
may not trigger alarm thresholds.  Second, if patients are unable to increase their RR in response 
to the lowering TV because of physiologic or iatrogenic (opioid administration) compromises, 
the MV decreases associated with removal of NIPPV could be higher.  If an average TV of 
500ml were to decrease by 25%, it would equate to about 125ml.  Since physiological dead space 
is about 150ml on average size patients, this decrease of 125ml is equivalent of the entire volume 
that does not participate in gas exchange.  This level of reduction in gas exchange may increase 
risk for atelectasis, delay elimination of residual inhaled anesthetics, and result in worsening of 
respiratory depression.  
 No prior studies were found where researchers used direct methods to observe changes in 
TV or MV while NPPV was used.  Researchers in prior studies relied upon invasive (Gaszynski 
et al., 2007; Wong et al., 2011) or indirect measurements (Nigelin et al., 2009) to determine 
effectiveness of NPPV therapy.  The effects of NPPV on ventilatory function were measured by 
removing the NPPV, then having the participant perform pulmonary function tests. 
 In the current study, participant compliance with NPPV therapy was similar to previous 
literature findings.  Consistently providing preoperative patient education about the importance 
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of proper NPPV use and potential benefits of wearing the mask may result in more compliant 
participants (Wong et al., 2011).  It is well known that when patients are instructed 
preoperatively about the use of NPPV they tend to be more complaint with keeping it on in the 
PACU.   
Study Limitations 
 This prospective observational study used a single convenience sample of relatively small 
size (n = 50) in absence of a priori power analysis.  By design, there was limited time for 
monitoring vital signs and respiratory parameters (45 minutes) in the PACU for participants.  
End-tidal CO2 was not utilized for comparative analyses, and application of oxygen was not 
randomized or applied similarly among participants.  Several factors increased homogeneity of 
the sample (BMIs, surgical durations, and type).  These factors increased the internal validity of 
the study, but may have limited generalizability of findings to other patients and surgical types.  
The single setting also limits generalizability of findings.  However, the research purposes were 
not only to observe ventilatory outcomes based on assigned OSA risk, but also to determine the 
feasibility of using a new innovative technology (RVM) in PACUs that might potentially alert 
providers earlier of changes in ventilatory patterns.  
 A major limitation of the study was small sample size in the NPPV group.  Only 15 
participants received NPPV therapy and data from only 13 was used for paired-samples analyses 
of therapy effects.  The information provided insights about the effects of therapy, but due to the 
small sample size, differences in outcomes between BCPAP vs. home CPAP could not be 
determined.  The fact that no participants received BiPAP therapy, and flow rates may have been 
inadequate with those who received BCPAP therapy were additional study limitations.  
Participants who reported using CPAP at home used a mean pressure support setting of 12cm 
85	
	
H2O.  Practitioners often chose oxygen flow settings at 15-liters/min when using BCPAP, which 
is not equivalent to 12cm H2O of support.  This lower support flow setting may have diminished 
the intended effects of BCPAP.  
 While important discoveries were made, the effects of NPPV therapy on ventilatory 
patterns were only measured for 15 minutes after application and removal.  It may be useful to 
measure ventilatory parameters for longer periods after removal of NPPV masks.  The only 
significant change in MV was seen between baseline MV values and MV upon mask removal.  It 
is possible that longer-term benefits of NPPV therapy exist.  In this study data was collected for 
the first 45 minutes of PACU stay.  
 Finally, while PACU nurses were unable to see the RVM screen, the RVM did sound an 
alarm when low MV events occurred.  The researcher remained at the bedside to pause the 
alarms, record data, and make observations of initiated interventions.  These factors may have 
led nurses to alter their routine cares, as an additional clinician was present.  Additionally, a 
Hawthorne effect cannot be excluded.  Nurses may have been more attentive than usual to the 
patient and may have caused increase in stimulation to the patient, reducing the actual 
effects/time percentage of low minute ventilation or desaturation events. 
Study Strengths 
  All consents were obtained and questionnaires conducted by the researcher who also was 
present during the postoperative period.  This provided consistency in data collection.  
Calibration of the RVM machine to the ventilator was performed in all but one instance by the 
researcher.  This increased validity and reliability of data as electrodes were placed in the correct 
sites.  If calibration efforts were not deemed accurate, recalibration attempts were made.  Data 
was excluded in 19% of participants relating to calibration issues, poor waveforms, or 
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inconsistent readings (n = 13).  This extended the data collection phase of the study, but 
increased reliability of results.   
 Vital signs and respiratory patterns were observed and measured by the researcher in a 
prospective manner.  The researcher controlled the data entry and recording of ventilatory 
output.  Since impedance devices (RVM) also assess movement (repositioning, talking, 
shivering, etc.), the researcher obtained values only when patients were resting quietly which   
facilitated error reduction in ventilatory values and provided more consistent data.  Data was 
entered directly into REDCap software system with back-up paper forms available when needed.  
This facilitated timely and accurate record keeping. 
 Another strength of the study was consistent researcher presence; ventilatory patterns 
were directly observed, increasing the validity of the findings.  In most instances (98%) the 
researcher escorted the participant with the anesthetist to the PACU, recording RVM data as 
needed and ensured PACU monitors were set at 5-minute intervals.  Having the researcher 
present allowed RVM output to be matched to the timing of interventions and correlated with 
vital signs.  All these processes in the research design ensured minimal error, making 
comparisons of data possible.  
 Finally, effects of NPPV therapy were measured in a unique way.  Using a noninvasive 
impedance device to measure the effects of NPPV therapy has not been reported in the literature 
and its use in the postoperative setting allowed detection of discreet changes in post-operative 
TV, RR, and MV.  The data were calculated and recorded during NPPV application and removal.  
All data recorded with participants quietly breathing which allowed more accurate assessments 
by eliminating the influence of secondary interventions (mask removal, spirometry studies, etc.). 
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Recommendations for Research 
 This dissertation revealed possibilities for additional research to more fully understand 
the effects of NPPV therapy, the use of the ExSpironTM respiratory volume monitor in measuring 
changes in ventilation, and the effects of opioids, neuromuscular blocking antagonists, and other 
medications have on ventilation.  Additional research is needed to explore what NPPV types, 
durations of application, and pressure settings best improve oxygenation and ventilation in 
patients with known or suspected OSA.  
 The results of this research have provided insights for future studies that can be 
implemented.  This prospective observational study did not control for many potentially 
confounding variables.  For instance, only 30% of the participants received postoperative NPPV 
therapy and initiation was at the discretion of the PACU RN or anesthetist.  The sample size was 
too small to determine how types of NPPV masks (BCPAP vs. home CPAP vs. BiPAP) affected 
outcome variables.  Prospective RCTs would help explore effects of different types of NPPV 
therapy as well as gain insight into the optimal duration of NPPV use. 
 Future research about effects of extended NPPV application as measured by the RVM 
would be beneficial.  This study measured ventilatory changes up to 15-minutes post-NPPV 
removal.  Additional measurements of ventilatory patterns after PACU discharge may provide 
addition information about NPPV therapy on patients with a diagnosis of OSA.  Larger 
prospective RCTs with a variety of patient populations (general surgery, thoracic, laparoscopic 
vs. open, etc.) are needed as most research to-date have relatively small sample sizes and/or are 
retrospective in nature. 
 The ExSpironTM RVM has been used to measure ventilatory states in a number of patient 
populations (Voscopoulos, et al. 2013).  These studies included monitoring for postoperative 
opioid respiratory depression (Voscopoulos et al., 2014), and the effects of sedation medications 
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during anesthetic cases (Ebert et al., 2015).  Additional perioperative insights can be sought 
using this technology to measure the effects of interventions aimed to improve patients’ 
respiratory status.  This could include the difference in ventilation when CPAP vs. BiPAP 
therapy is used, home CPAP vs. hospital NPPV therapy, and the perioperative effects of using 
NPPV therapy upon admission to the PACU vs. as a rescue therapy.  Findings may eventually be 
used to develop practice standards with a goal of reducing potential complications for those 
known or suspected of having OSA. 
 Finally, the RVM can be used to measure ventilatory parameters and the effects of 
various medications.  For instance, participants received sugammadex or neostigmine for non-
depolarizing neuromuscular blocking antagonism.  Selection of specific drugs and dosages were 
at the discretion of the anesthetists.  As each mechanism of action is different, it would be 
beneficial to further understand the perioperative and clinical effects of reversal technique in this 
patient population.  Performing research where participants randomized into neostigmine or 
sugammadex medication-groups and measuring ventilatory parameters in the PACU with the 
RVM may help clinicians make informed clinical decisions about selection of neuromuscular 
reversal agents.  Similar studies could include observing the effects of opioids and other sedative 
medications or multimodal approaches for analgesia.  
Implications for Practice 
 The results of this research have led to additional insights for evolving clinical practice.  
Four main implications for clinical practice were found in the study.  This includes insights into 
screening for OSA, monitoring for respiratory depression, titration and removal of oxygen, and a 
more proactive approach to using NPPV to maintain ventilation throughout the PACU stay.  A 
review of these implications is as follows. 
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Use of the STOP-Bang Questionnaire  
 There may be mixed usefulness of using STOP-Bang Questionnaire (SBQ) to assign 
OSA risk, as assignment of that risk does not predict risk of adverse postoperative respiratory 
events.  It may be important to identify those at-risk of adverse postoperative respiratory events 
by reviewing other objective measures (Deflandre et al., 2017).  The SBQ is a quick screening 
tool for identifying OSA.  If certain responses are noted positive: Age >50 years, neck 
circumference >40cm, male gender, or history of snoring or airway obstruction; or an aggregate 
score ≥3 is determined, the patient is presumed to have OSA.  Strategies can be employed to 
reduce potential postoperative ventilatory complications.   
 The results of the SBQ or other preoperative screening tools should be placed on the 
patients chart for all practitioners to see.  In this study no numerical values of preoperative SBQ 
scores were noted.  The SBQ or similar questionnaires can be easily administered in the 
preoperative clinic, allowing a follow-up consultation to be arranged as needed.   
 Strategies used to reduce postoperative respiratory depression should be implemented 
(multimodal pain management, regional anesthetic techniques, supportive airway devices, etc.) 
with patients suspected of having any potential for OSA.  Additionally, as general guidelines 
exist for screening and management of OSA (Gross et al., 2014), those with any risk may benefit 
from improved monitoring strategies.  The RVM may be used for this problem as the ventilatory 
changes can be continuously monitored in the PACU.  As previously mentioned, this takes a 
more universal approach to monitoring for respiratory depression, potentially reducing and/or 
eliminating postoperative airway events.    
Proactive Use of Postoperative NPPV Therapy 
 The American Society of Anesthesiologists appointed a task force to review relevant 
literature and establish general guidelines for perioperative management of patients with OSA 
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(Gross et al., 2006; Gross et al., 2014).  They developed and updated general management 
guidelines that include: establishing screening protocols, assuring physical examinations, and 
assigning patient’s risk level and including postoperative designation (in-patient vs. outpatient).  
Guidelines promote the advising of patients to be compliant with home CPAP and to bring their 
devices with them the day of surgery.  Guidelines also encourage placing patients in the non-
supine position and using regional anesthesia for pain relief when possible.  There was a lack of 
sufficient literature to support recommendations about use of opioids and oxygen use post-
operatively.  Continuous monitoring such as pulse oximetry was advocated as “effective in 
detecting hypoxemic events” (Gross et al., 2014, p. 273).  However with the use of oxygen, 
hypoventilation or apnea events may be prolonged or missed.  These basic guidelines for practice 
need to be understood and implemented consistently.   
 Additional modifications of these guidelines may be appropriate based upon individual 
patient risk, surgical type and duration.  Some modifications might include having all OSA 
positive patients bring and use their home NPPV mask on admission to PACU as needed instead 
of waiting until they are discharged to step down units.  Earlier use of NPPV appears to attenuate 
the effects of OSA and potentially reduce longer-term ventilatory complications.   
 NPPV therapy (BCPAP or other CPAP devices) could be initiated upon arrival in PACUs 
for those known to be at any risk for OSA.  Finally, using monitors to measure ventilatory 
function could improve care.  The RVM has been demonstrated in various populations to detect 
hypoventilation states (Ebert et al., 2015; Holley et al., 2016; Voscopoulos et al., 2014).  The 
device can be used to detect respiratory depression and monitor for the effects of opioids and 
other medications that affect postoperative ventilatory patterns.  
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Standardized Use of RVM Monitor For At-Risk Populations 
 As there is a percentage of the surgical population with undiagnosed OSA (Finkel, et al., 
2009) or the potential for OSA-related breathing problems, it may be prudent to see all patients 
as having an equal risk for airway obstruction.  Implementing a standardized method of 
measuring ventilatory function may mitigate potential and actual airway events.  The RVM is a 
noninvasive machine that measures changes in RR and TV to continuously calculate MV and can 
used in the PACU setting to identify states of hypoventilation, effects of opioids or other 
medications, and changes in ventilatory patterns after interventions.   
 Practitioners should reduce/limit opioids in patients with known OSA and observe them 
more closely after each medication administration.  By adjusting RVM alarms for RR and TV 
changes to identify low TV/RR in addition to a decline in MV, respiratory depression may be 
identified earlier.  RVM alarms can be changed to notify a drop in MV at the MV <pred60% 
instead of the preset MV <pred40% or a decrease in RR at 12 vs. 10 breaths/min.  This 
information may be used to adjust opioid administration, change analgesic types, including 
dosages and frequencies, and measure the effects of interventions aimed to improve ventilatory 
parameters. 
 The RVM can be implemented and used as a standard monitor in the PACU and inpatient 
settings.  Newer software also aids in performing a universal calibration (Respiratory Motion 
Inc., 2017) to minimize time in setting up the device when needed.  The monitor can display 
numerical data and graph trends to ease understanding of information, guide therapies and 
interventions.  This is important for several reasons.  First, individual responses to general 
anesthesia, medications, and interventions are present.  Second, pulse oximetry has limitations in 
alerting RNs for hypoventilation, especially if supplemental oxygen is used.  Finally, the RVM 
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provides direct, non-invasive feedback on interventions and therapies given, presenting 
continuous information to guide interventions in real-time. 
Strategies for Earlier Identification of Hypoventilation 
 In this study, the RVM was found to have superior ability to detect states of 
hypoventilation over standard pulse oximetry readings.  Only when oxygen therapy was 
discontinued did pulse oximetry begin to reflect ventilatory declines.  Two implications are 
suggested from these findings.  First, the RVM is a potentially important adjunct to standard 
monitors to measure RR, TV, and MV to alert PACU RNs and anesthesia providers of changes 
in patients’ ventilatory status.  The information can be used to adjust medications as stated 
previously as well as the monitor effects of interventions on ventilatory status.  
 Second, oxygen is a medication and its effects can be therapeutic as well as deleterious.  
One practice aim should be to minimize and ultimately wean oxygen flows off as soon as 
patients can maintain satisfactory oxygen saturation without supplemental oxygen.  In this study, 
a significant negative association between “desaturation events to oxygen use” was 
demonstrated: Desaturation events matched hypoventilation events 46.8% of the time when no 
oxygen was used vs. 8.9% when supplemental oxygen was used.  This may indicate that 
supplemental oxygen confounds or clouds real or potential hypoventilation/apnea states.  
Although no re-intubations or transfers to the ICU occurred, some participants who required 
NPPV therapy had delayed PACU discharges, and experienced periods of hypoventilation 
unknown to the RN.  It seems prudent to reduce and discontinue oxygen therapy as soon as it is 
no longer indicated when devices that directly measure ventilatory function are not used.  Pulse 
oximetry changes would then be better at alerting nurses of low oxygen saturations reflecting 
ventilatory depression.  
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Proactive use of NPPV Therapy 
 Despite a low number of total NPPV applications in this study, benefits of maintaining 
MV were noted.  The benefit of improving MV was not statistically significant during the initial 
15-minute application period.  This implies that the effect takes longer than 15 minutes of 
therapy to achieve desired MV.  Thus it may be prudent to apply NPPV immediately after 
extubation until the patient fully participates in their care and is without symptoms of respiratory 
depression.  
 If providers choose to use the BCPAP, flow rates of 25 liters/min will approximate 10cm 
H2O.  Instead of using high flow of oxygen, air can be used in the PACU as an alternative source 
to supply the mask pressure.  This would decrease unnecessary use of oxygen and increase the 
effectiveness of using O2 saturation as an indicator of respiratory depression.  The use of 
patient’s home CPAP can be initiated earlier as well, but may need coordination with respiratory 
therapy if additional oxygen is needed as it must be entrained into the supply line.  Previous 
researchers have noted the benefit of immediate NPPV therapy after extubation (Laio et al., 
2013; Gaszynski et al., 2007).  It may be prudent to apply home or hospital-provided NPPV on 
arrival to the PACU after initial assessment by the RN is completed. 
Implications for Nursing Education 
 The use of new technology requires training practitioners associated with its use.  Nurses 
use assessment skills, standard monitors, and patients’ responses to therapies to guide cares.  
Various monitors are used based upon patient’s physical status and the types of surgical 
procedures performed.  Providing instruction about the differences between ventilation and 
oxygenation as well as how to use data from RVMs will be required.  While use of pulse 
oximetry can improve understanding of ventilatory status when oxygen is not used, most patients 
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are transferred to PACU with supplemental oxygen.  Finally, pulse oximetry readings can be 
obscured by changes in patient’s positioning, and temperature (Voepel-Lewis et al., 2013). 
 End-tidal CO2 (capnography) monitoring is also beneficial in the PACU to observe 
patient’s respiratory patterns but capnography also has limitations.  Respiratory volumes are not 
calculated and higher oxygen flow rates can washout the sampling stream.  If capnography is 
used, multi-port sampling lines are suggested (Hess & Kaczmarek, 2012) to reduce sampling 
error.  For these reasons, nurses should not rely upon capnography alone to estimate ventilatory 
function.  At-risk OSA patients may benefit from using capnography in addition to the RVM 
technology with a RN that understands how to use the data these devices provide.  
Conclusions 
 This dissertation study explored the relationship of OSA severity on ventilatory outcomes 
after general anesthesia as well as the effects of non-invasive positive pressure ventilation in the 
PACU using an innovative non-invasive but direct-measuring respiratory volume monitor 
(RVM).  The RVM was able to identify apnea and hypoventilation events in most cases before 
any decrease in pulse oximetry was observed.  This supports an indication that this innovative 
technology should be studied further for implementation into clinical practice.    
The processes of conducting this study have provided several insights for future research and 
practice.  Some of the assumptions were confirmed during the data collection and statistical 
analyses of the findings.  This included further support that pulse oximetry is a tool for 
measuring blood oxygenation saturation as a proxy measure for adequacy of patient ventilation.  
It has limited value when used to identify hypoventilation events in OSA patients, especially 
when supplemental oxygen is in use.  Additionally, patients with or suspected of having OSA are 
at risk for postoperative ventilatory impairments including airway obstructions, desaturations, 
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and periods of hypoventilation that may lead to additional complications in the perioperative 
setting.   
 The frequencies of respiratory events were not significantly different between OSA 
assigned groups.  This finding suggested that all patients should be managed in similar ways for 
identifying and reducing respiratory events.  However, sample size for this study was relatively 
small and homogenous as it related to participant’s BMI, surgical type and duration, and 
postoperative outcomes.  Additional studies with larger and various populations, BMIs, and 
procedures are needed to increase the external validity and generalizability of these findings.  
 Routine postoperative monitors (pulse oximetry, and ECG respiratory leads) provided 
limited and indirect information about patients’ ventilatory status when potential or real events 
occurred.  PACU RNs are faced with a variety of challenges that compete for their attention.  
While collecting data, the researcher observed patients being admitted, stabilized, and discharged 
in a cyclical fashion.  Often, after the RN gave opioids and other medications, or assessed the 
participant, they turned their attention to charting or to the care of other patients.  The monitors 
that RNs used to alert them to changes in participant’s ventilatory status were pulse oximetry, 
heart rate, and ECG respiratory leads.  None of these monitors were able to calculate minute 
ventilation.  If the RN was not directly viewing the patient, hypoventilation and obstructive states 
could and often did go unnoticed.  This provided additional support for using RVM technology 
to continuously monitor and measure ventilatory states and alert clinicians to changes in 
ventilatory function, especially when their attention is on care of other patients.  
 The RVM alarms alert clinicians of hypoventilatory or apneic states and increase 
awareness of changes in patient’s ventilatory status and provide digital feedback of ventilatory 
patterns from interventions initiated.  This includes identification of hypoventilation patterns and 
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effects of interventions aimed to improve respiratory function in spontaneously breathing 
patients.  The technologically advanced (RVM) monitor was used to compare ventilatory 
outcomes between OSA groups, and the effects of NPPV therapy on ventilation.  To date, the 
RVM has not been incorporated for use in the perioperative setting for all patient populations.  
Data from the RVM alerted the principle investigator to apnea and hypoventilation in most cases 
before any decrease in pulse oximetry was seen.  This supports the indication that this innovative 
technology should be studied further for adoption into clinical practice. 
 Effects of NPPV therapy on ventilation were observed and recorded for 15 participants.  
Despite the low number for statistical analysis (n = 13), insights were gained into the effects of 
both BCPAP and home CPAP application in the PACU.  Future RCTs using this RVM 
technology to measure ventilatory states for different NPPV interventions have the potential to 
provide researchers with additional insights into best-practice strategies.  Longer application 
times and data collection periods are needed to further explore NPPV benefits in the 
perioperative setting.  Additionally, using the RVM with various surgical populations and 
settings would increase the generalizability of the findings.  By performing additional research in 
these areas, insights into best practice strategies may be formed and provide a basis for universal 
approach to managing any “at risk” patient for OSA.  
 Finally, if insights gained from this study go unnoticed, or future research does not 
advance from these findings, anesthesia providers and PACU RNs may be providing care in an 
ineffective/reactive manner.  It is essential that proactive methods for identifying and managing 
ventilation issues for OSA at-risk patients be implemented.  Patients with co-existing diseases 
(including OSA) require additional attention from perioperative team members.  Management 
strategies to mitigate potential and real problems during a patient’s perioperative stay need to be 
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in place and used.  Future research is needed to develop efficient ways to identify which 
preoperative questions and patient characteristics may identify an OSA patient.  On the other 
hand, it may be more efficient to see all patients as “at risk” and use RVM technology on 
everyone preemptively.  Practice standards and clear plans for approaching the care and 
management of postoperative pain, hydration, oxygenation, and ventilation states in the 
perioperative period need to be continually modified to fit this unique patient population.   
 As suggested earlier, the use of NPPV during the PACU recovery period needs additional 
research to gain insights for practice standards to mitigate airway events in the OSA surgical 
population.  By incorporating findings of this study, hypoventilation states may be identified 
more readily and proactive measures may be initiated earlier to reduce airway events and support 
ventilation.  Additional research, including larger RCTs with various surgical populations should 
be implemented to support the findings of this dissertation study.  Overall, findings gleaned from 
this dissertation may provide a path into future endeavors for improving healthcare management 
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1. Snoring: Do you snore loudly (loud enough to be heard through closed doors)? 
   Yes   No  
 
2. Tired: Do you often feel tired, fatigued, or sleepy during daytime?  
  Yes  No  
 
3. Observed: Has anyone observed you stop breathing during your sleep?  
  Yes  No  
 
4. Blood Pressure: Do you have or are you being treated for high blood pressure?  
  Yes  No  
 
5. BMI: BMI more than 35 kg/m2?  
  Yes  No  
 
6. Age: Age over 50 years old?  
  Yes  No  
 
7. Neck circumference: Neck circumference greater than 40 cm?  
  Yes  No  
 
8. Gender: Male?  
  Yes  No  
 





APPENDIX D: MODIFIED ALDRETE SCORING SYSTEM FOR PACU DISCHARGE 
 
Modified Aldrete Scoring System For PACU Discharge 
Criteria Patient status Score 
 
Activity 
Able to move four extremities voluntarily on command 2 
Able to move two extremities on command 1 
Unable to move 0 
 
Respiration 
Able to deep breath and cough freely 2 




BP and HR ± 20% of preanesthetic level 2 
BP and HR ± 20% to 50% of preanesthetic level  1 
BP and HR ± 50% of preanesthetic level  0 
 
Consciousness 
Fully awake (able to answer questions) 2 




Able to maintain O2 saturation >92% on room air 2 
Needs O2 inhalation to maintain saturation >92% 1 
O2 saturation <90% even with O2 supplement 0 
 









You are Invited to 
Participate in a 
Research Study 
Purpose: To understand the effects of surgery and general 
anesthesia on breathing patterns of people with known or 
suspected obstructive sleep apnea.  Results of the study may 
help improve patient outcomes and identify additional ways to 
monitor patients safely. 
Who can participate? Individuals undergoing gastric bypass 
(Gastric Sleeve or Roux‐en Y) surgery. 
What you need to do? Briefly discuss your sleep and health 
history before surgery.  After surgery your breathing patterns 
will be monitored with a portable monitor attached to you by 
electrodes and calibrated during surgery.  
Where will it take place? In the surgical area and recovery 
room at the hospital the day of your surgery. 
How long will it take? 10‐15 minutes for questions and minimal
time for placing electrodes.  Monitoring will be performed in 
addition to standard monitors used in the recovery room.  
You will be contacted in person the morning of your surgery to 
discuss the study in more detail.  If interested or have 
questions prior to your surgery date, please call Travis Chabo, 
MSN, CRNA, PhD Candidate at 252‐744‐6401.   
	
	



















































































































































































Principal Investigator:  I have conducted the initial informed consent process.  I have orally 
reviewed the contents of the consent document with the person who has signed above, and 
answered all of the person’s questions about the research. 
	
































[ ]	ECU	Physicians																																																		 [ ]	Entire	Vidant	Health	system		
[ ]	School	of	Dental	Medicine																																	 [ ]	Vidant	Medical	Center		
[ ]	Speech,	Language,	and	Hearing	Clinic														[ ]	Other	Vidant	Health	Entity		
[ ]	Human	Performance	Lab		 	 	 (please	list):			 	 	 	 	 																																																											
[ ]	Physical	Therapy	 	 	 																																														





[ ]	Medical/clinic	records	 	 	 	 [ ]	Medical/clinic	records	
[ ]	Billing	records																																																 [ ]	Billing	records																																																
[ ]	Lab,	Pathology	and/or	Radiology	results								[ ]	Lab,	Pathology	and/or			 	
	 	 	 	 	 	 									 										Radiology	results	
[ ]	Mental	Health	records														 	 	 [ ]	Mental	Health	records	
[ ]	PHI	previously	collected	for	research					 [ ]	PHI	previously	collected	for	research	
[ ]	Records	generated	during	this	study	 	 [ ]	Records	generated	during	this	study	























[ ]			Researchers	at	other	sites—List	sites:		 	 	 	 	 	
[ ]			Data	and	Safety	Monitoring	Board	and	its	staff	
[ ]			Contract	Research	Organization	and	its	staff	







































































APPENDIX G: OSA AND BARIATRIC SURGERY PREOPERATIVE DATA SHEET 
 
OSA And Bariatric Surgery Preoperative Data Sheet 
 
 
Name: _______________________________ Surgery Date: ______________ ID#: _________ 
 
Surgery Type: (GS): _____ (RY): ______  
Participant Demographics 
Age (years): ____ Gender (M): ____ (F): ____Height (cm): _____Weight (kg): ____ BMI: ____ 
Ethnicity (check one):  
 Hispanic or Latino: _____ Not Hispanic or Latino: _____ Unknown: _____ 
Race (check one):  
 American Indian/Alaskan Native: _____ Asian: _____ Hawaiian/Pacific Islander: _____  
 Black or African American: _____ White/Caucasian: _____ Hispanic/Latino: _____ 
 Other: _____
Health History (check if yes)
Hypertension: _____ 
Atrial Fibrillation: _____ 
Diabetes Mellitus: _____ 
Asthma: _____ 
COPD: _____ 
Orthopnea (>1 pillow at night): _____ 
Dyspnea on Exertion: _____ 










STOP-Bang Questionnaire (Chung et al., 2008) (Check of yes) 
1. Snoring: Do you snore loudly (loud enough to be heard through closed doors)? _____ 
2. Tired: Do you often feel tired, fatigued, or sleepy during daytime? _____ 
3. Observed: Has anyone observed you stop breathing during your sleep? _____ 
4. Blood Pressure: Do you have or are you being treated for high BP? _____ 
5. BMI: BMI more than 35 kg/m2? _____ 
6. Age: Age over 50 years old? _____ 
7. Neck circumference: Neck circumference greater than 40 cm? _____ 
8. Gender: Male? _____ 
Obstructive Sleep Apnea History 
STOP-Bang Score (#): _____ 
Neck Circumference (cm): _____ 
Formal OSA History (check if yes): _____  
AHI Score (#): _____ 
Epworth Sleepiness Score (#): __
NPPV Type (check one)  
 BiPAP: ____ CPAP: ____ 
Home NPPV Use greater than 4hrs/night (check if yes): _____ 
Home NPPV Pressure Setting (cm H2O)  
 CPAP: ____ BiPAP: ____/____ 
Assigned OSA Group Based on STOP-Bang Score (Mild, 1-3; Moderate/Severe, 4-8) 










Face Mask Oxygen flow
Boussignac CPAP 








 Intraoperative Neuromuscular Blocking Antagonists, Opioid Antagonist, and 



































Purpose: To observe the effects of surgery and general anesthesia on 
postoperative ventilatory patterns of known or suspected OSA patients 
after gastric bypass surgery using non‐invasive impedance technology. 
Participants: Individual patients of Southern Surgical Physicians 
undergoing gastric bypass (Gastric Sleeve or Roux‐en Y) surgery. 
Process:  
1. Participants will be screened and consented prior to surgery. 
2. At the completion of the participant’s surgery, but before 
extubation, the ExSpironTM monitor and disposable padset will be 
applied to the participant.  The monitor will be calibrated to the 
anesthesia ventilator prior to extubation.   
3. The monitor will be transported with the participant to the PACU 
and used to continuously monitor ventilatory patterns. 
4. The PI will record ventilatory patterns and vitals signs for analyses 
as well as timing, duration, and effects of NPPV therapy when 
used during the PACU period. 
How can you help?  Anesthesia providers please assist in calibration of 
the ExSpironTM in the OR to the ventilator and take the machine 
connected to the patient to the PACU.  No changes to the anesthetic 
plan are needed. PACU RNs continue providing standard nursing cares, 
please keep electrodes on during the PACU period for data collection. 
If you have any questions regarding the research study please see the 
PI: Travis Chabo, MSN, CRNA, PhD Candidate or call 740‐202‐0187. 
Thank you! 
	
	
	
 
